| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.838 | 0.003 | 0.838 | DNA synthesis inhibitor | 0.346 0.031 DBMET00638 | ||
| 0.747 | 0.006 | 0.747 | Antibacterial | 0.404 0.075 DBMET00638 | ||
| 0.671 | 0.004 | 0.671 | Topoisomerase II inhibitor | 0.16 0.045 DBMET00638 | ||
| 0.516 | 0.003 | 0.516 | DNA gyrase inhibitor | |||
| 0.389 | 0.002 | 0.389 | DNA topoisomerase IV inhibitor | |||
| 0.367 | 0.002 | 0.367 | DNA gyrase subunit A inhibitor | |||
| 0.28 | 0.003 | 0.28 | Topoisomerase II beta inhibitor | 0.058 0.023 DBMET00638 | ||
| 0.253 | 0.003 | 0.253 | DNA gyrase subunit B inhibitor | |||
| 0.246 | 0.017 | 0.257 | Cell wall synthesis inhibitor | 0.257 0.014 DBMET00638 | DBMET00638 | |
| 0.226 | 0.021 | 0.226 | Topoisomerase I inhibitor | 0.165 0.036 DBMET00638 | ||
| 0.206 | 0.02 | 0.206 | Antibacterial (Helicobacter pylori) | 0.141 0.055 DBMET00638 | ||
| 0.227 | 0.095 | 0.379 | DNA damaging | 0.379 0.033 DBMET00638 | DBMET00638 | |
| 0.288 | 0.168 | 0.339 | Calcium channel L-type activator | 0.339 0.126 DBMET00638 | DBMET00638 | |
| 0.143 | 0.046 | 0.442 | DNA intercalator | 0.442 0.006 DBMET00638 | DBMET00638 | |
| 0.11 | 0.044 | 0.281 | Protein kinase C delta inhibitor | 0.281 0.004 DBMET00638 | DBMET00638 | |
| 0.071 | 0.014 | 0.071 | Growth hormone secretagogue receptor agonist | 0.054 0.017 DBMET00638 | ||
| 0.061 | 0.005 | 0.061 | Motilin receptor agonist | |||
| 0.216 | 0.163 | 0.467 | Interleukin 2 agonist | 0.467 0.013 DBMET00638 | DBMET00638 | |
| 0.073 | 0.023 | 0.073 | Protein 50S ribosomal subunit inhibitor | |||
| 0.083 | 0.036 | 0.083 | HIV-1 integrase inhibitor | |||
| 0.071 | 0.03 | 0.071 | Cyclin-dependent kinase 6 inhibitor | 0.071 0.03 DBMET00638 | ||
| 0.07 | 0.047 | 0.112 | Protein kinase C beta inhibitor | 0.112 0.009 DBMET00638 | DBMET00638 | |
| 0.032 | 0.011 | 0.032 | DNA polymerase III inhibitor | |||
| 0.065 | 0.046 | 0.065 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.047 | 0.03 | 0.058 | 5 Hydroxytryptamine 2C agonist | 0.058 0.022 DBMET00638 | DBMET00638 | |
| 0.17 | 0.154 | 0.17 | Streptokinase A inhibitor | |||
| 0.048 | 0.035 | 0.048 | CC chemokine receptor 2B antagonist | |||
| 0.017 | 0.004 | 0.017 | DNA polymerase III polC-type inhibitor | |||
| 0.04 | 0.033 | 0.191 | GHS receptor agonist | 0.191 0.004 DBMET00638 | DBMET00638 | |
| 0.044 | 0.039 | 0.044 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.047 | 0.048 | 0.217 | Protein kinase C eta inhibitor | 0.217 0.004 DBMET00638 | DBMET00638 | |
| 0.158 | 0.16 | 0.378 | Interleukin agonist | 0.378 0.022 DBMET00638 | DBMET00638 | |
| 0.042 | 0.068 | 0.059 | Nicotinic receptor alpha7 subunit antagonist | 0.059 0.03 DBMET00638 | DBMET00638 | |
| 0.097 | 0.128 | 0.668 | Protein kinase C nu inhibitor | 0.668 0.004 DBMET00638 | DBMET00638 | |
| 0.008 | 0.042 | 0.046 | Nociceptin (N/OFQ) receptor agonist | 0.046 0.006 DBMET00638 | DBMET00638 | |
| 0.037 | 0.072 | 0.056 | 5 Hydroxytryptamine 3 antagonist | 0.056 0.041 DBMET00638 | DBMET00638 | |
| 0.041 | 0.075 | 0.13 | 5 Hydroxytryptamine 2A agonist | 0.13 0.007 DBMET00638 | DBMET00638 | |
| 0.027 | 0.08 | 0.05 | Phenylethanolamine N methyltransferase inhibitor | 0.05 0.014 DBMET00638 | DBMET00638 | |
| 0.008 | 0.065 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 DBMET00638 | DBMET00638 | |
| 0.03 | 0.088 | 0.089 | 5 Hydroxytryptamine 2 agonist | 0.089 0.012 DBMET00638 | DBMET00638 | |
| 0.099 | 0.16 | 0.311 | Angiogenesis stimulant | 0.311 0.045 DBMET00638 | DBMET00638 | |
| 0.024 | 0.091 | 0.044 | Glutamate (mGluR8) antagonist | 0.044 0.013 DBMET00638 | DBMET00638 | |
| 0.043 | 0.11 | 0.199 | Protein kinase C alpha inhibitor | 0.199 0.005 DBMET00638 | DBMET00638 | |
| 0.05 | 0.117 | 0.087 | 5 Hydroxytryptamine 2C antagonist | 0.087 0.055 DBMET00638 | DBMET00638 | |
| 0.018 | 0.089 | 0.035 | Nicotinic receptor beta4 subunit antagonist | 0.035 0.029 DBMET00638 | DBMET00638 | |
| 0.084 | 0.157 | 0.153 | Activin receptor-like kinase 2 inhibitor | 0.153 0.064 DBMET00638 | DBMET00638 | |
| 0.006 | 0.087 | 0.075 | Somatostatin 2 agonist | 0.075 0.004 DBMET00638 | DBMET00638 | |
| 0.031 | 0.13 | 0.085 | Neuronal nicotinic receptor antagonist | 0.085 0.032 DBMET00638 | DBMET00638 | |
| 0.082 | 0.181 | 0.228 | Acetylcholine M1 receptor antagonist | 0.228 0.032 DBMET00638 | DBMET00638 | |
| 0.058 | 0.16 | 0.106 | Polo-like kinase-1 inhibitor | 0.106 0.039 DBMET00638 | DBMET00638 | |
| 0.126 | 0.234 | 0.75 | 5 Hydroxytryptamine release stimulant | 0.75 0.005 DBMET00638 | DBMET00638 | |
| 0.029 | 0.136 | 0.068 | 5 Hydroxytryptamine 3A antagonist | 0.068 0.045 DBMET00638 | DBMET00638 | |
| 0.034 | 0.144 | 0.128 | 5 Hydroxytryptamine 3 agonist | 0.128 0.007 DBMET00638 | DBMET00638 | |
| 0.068 | 0.181 | 0.604 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.604 0.004 DBMET00638 | DBMET00638 | |
| 0.023 | 0.137 | 0.163 | 5 Hydroxytryptamine agonist | 0.163 0.019 DBMET00638 | DBMET00638 | |
| 0.049 | 0.167 | 0.369 | Protein kinase C mu inhibitor | 0.369 0.004 DBMET00638 | DBMET00638 | |
| 0.025 | 0.148 | 0.353 | CXC chemokine 4 receptor antagonist | 0.353 0.004 DBMET00638 | DBMET00638 | |
| 0.014 | 0.138 | 0.066 | Guanylate cyclase inhibitor | 0.066 0.007 DBMET00638 | DBMET00638 | |
| 0.02 | 0.149 | 0.074 | 5 Hydroxytryptamine 2B agonist | 0.074 0.005 DBMET00638 | DBMET00638 | |
| 0.119 | 0.249 | 0.727 | Superoxide dismutase inhibitor | 0.727 0.004 DBMET00638 | DBMET00638 | |
| 0.031 | 0.161 | 0.11 | Nicotinic alpha4beta2 receptor antagonist | 0.11 0.024 DBMET00638 | DBMET00638 | |
| 0.051 | 0.182 | 0.099 | 5 Hydroxytryptamine 2B antagonist | 0.099 0.084 DBMET00638 | DBMET00638 | |
| 0.02 | 0.16 | 0.248 | Protein kinase C epsilon inhibitor | 0.248 0.003 DBMET00638 | DBMET00638 | |
| 0.032 | 0.174 | 0.079 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 DBMET00638 | DBMET00638 | |
| 0.005 | 0.15 | 0.019 | Nicotinic alpha4 receptor agonist | 0.019 0.008 DBMET00638 | DBMET00638 | |
| 0.031 | 0.177 | 0.053 | Factor III inhibitor | 0.053 0.027 DBMET00638 | DBMET00638 | |
| 0.04 | 0.188 | 0.097 | MAP-kinase-activated kinase inhibitor | 0.097 0.042 DBMET00638 | DBMET00638 | |
| 0.02 | 0.168 | 0.096 | Acetylcholine M5 receptor agonist | 0.096 0.023 DBMET00638 | DBMET00638 | |
| 0.031 | 0.182 | 0.104 | Acetylcholine nicotinic antagonist | 0.104 0.037 DBMET00638 | DBMET00638 | |
| 0.03 | 0.186 | 0.112 | Phospholipase D inhibitor | 0.112 0.009 DBMET00638 | DBMET00638 | |
| 0.019 | 0.178 | 0.081 | 5 Hydroxytryptamine 6 antagonist | 0.081 0.022 DBMET00638 | DBMET00638 | |
| 0.051 | 0.214 | 0.134 | Acetylcholine antagonist | 0.134 0.059 DBMET00638 | DBMET00638 | |
| 0.019 | 0.182 | 0.076 | Protein kinase C theta inhibitor | 0.076 0.017 DBMET00638 | DBMET00638 | |
| 0.01 | 0.177 | 0.032 | CDK4/cyclin D3 inhibitor | 0.032 0.015 DBMET00638 | DBMET00638 | |
| 0.051 | 0.219 | 0.137 | Cholinergic antagonist | 0.137 0.06 DBMET00638 | DBMET00638 | |
| 0.003 | 0.174 | 0.028 | Melanocortin 3 antagonist | 0.028 0.02 DBMET00638 | DBMET00638 | |
| 0.016 | 0.19 | 0.057 | Nerve growth factor antagonist | 0.057 0.011 DBMET00638 | DBMET00638 | |
| 0.03 | 0.205 | 0.084 | MAP-kinase-activated kinase 2 inhibitor | 0.084 0.04 DBMET00638 | DBMET00638 | |
| 0.053 | 0.228 | 0.38 | CDC-like kinase 2 inhibitor | 0.38 0.016 DBMET00638 | DBMET00638 | |
| 0.077 | 0.254 | 0.147 | DNA repair enzyme inhibitor | 0.147 0.034 DBMET00638 | DBMET00638 | |
| 0.036 | 0.213 | 0.261 | Pim-1 kinase inhibitor | 0.261 0.008 DBMET00638 | DBMET00638 | |
| 0.036 | 0.216 | 0.118 | Pim-3 kinase inhibitor | 0.118 0.032 DBMET00638 | DBMET00638 | |
| 0.098 | 0.279 | 0.308 | 5 Hydroxytryptamine 1E antagonist | 0.308 0.025 DBMET00638 | DBMET00638 | |
| 0.01 | 0.191 | 0.077 | Melanocortin 4 antagonist | 0.077 0.013 DBMET00638 | DBMET00638 | |
| 0.02 | 0.201 | 0.049 | ATM kinase inhibitor | 0.049 0.009 DBMET00638 | DBMET00638 | |
| 0.045 | 0.231 | 0.168 | Protein kinase C zeta inhibitor | 0.168 0.016 DBMET00638 | DBMET00638 | |
| 0.017 | 0.203 | 0.059 | Neuraminidase (Influenza A) inhibitor | 0.059 0.014 DBMET00638 | DBMET00638 | |
| 0.018 | 0.205 | 0.075 | Pim-2 kinase inhibitor | 0.075 0.022 DBMET00638 | DBMET00638 | |
| 0.054 | 0.242 | 0.11 | Cytokine production inhibitor | 0.11 0.1 DBMET00638 | DBMET00638 | |
| 0.005 | 0.193 | 0.147 | Somatostatin 5 antagonist | 0.147 0.005 DBMET00638 | DBMET00638 | |
| 0.016 | 0.211 | 0.068 | 5 Hydroxytryptamine 1D antagonist | 0.068 0.04 DBMET00638 | DBMET00638 | |
| 0.12 | 0.316 | 0.529 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.529 0.005 DBMET00638 | DBMET00638 | |
| 0.033 | 0.236 | 0.076 | Ryanodine receptor antagonist | 0.076 0.011 DBMET00638 | DBMET00638 | |
| 0.01 | 0.216 | 0.369 | Somatostatin agonist | 0.369 0.004 DBMET00638 | DBMET00638 | |
| 0.007 | 0.214 | 0.123 | AMPA 2 receptor antagonist | 0.123 0.005 DBMET00638 | DBMET00638 | |
| 0.041 | 0.249 | 0.059 | Prolactin release inhibitor | 0.059 0.056 DBMET00638 | DBMET00638 | |
| 0.005 | 0.212 | 0.025 | Dipeptidyl peptidase IX inhibitor | 0.025 0.007 DBMET00638 | DBMET00638 | |
| 0.044 | 0.254 | 0.115 | Bromodomain-containing protein 2 inhibitor | 0.115 0.026 DBMET00638 | DBMET00638 | |
| 0.076 | 0.287 | 0.777 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.777 0.004 DBMET00638 | DBMET00638 | |
| 0.013 | 0.225 | 0.111 | Melanocortin antagonist | 0.111 0.01 DBMET00638 | DBMET00638 | |
| 0.005 | 0.218 | 0.02 | Dipeptidyl peptidase VIII inhibitor | 0.02 0.007 DBMET00638 | DBMET00638 | |
| 0.072 | 0.288 | 0.188 | Hemostatic | 0.188 0.038 DBMET00638 | DBMET00638 | |
| 0.02 | 0.236 | 0.088 | Acetylcholine M4 receptor antagonist | 0.088 0.039 DBMET00638 | DBMET00638 | |
| 0.003 | 0.221 | 0.023 | Sigma 2 receptor antagonist | 0.023 0.022 DBMET00638 | DBMET00638 | |
| 0.028 | 0.248 | 0.108 | Glutamate (mGluR7) antagonist | 0.108 0.007 DBMET00638 | DBMET00638 | |
| 0.026 | 0.25 | 0.065 | Pregnane X receptor antagonist | 0.065 0.021 DBMET00638 | DBMET00638 | |
| 0.023 | 0.248 | 0.126 | Cyclin-dependent kinase 1 inhibitor | 0.126 0.052 DBMET00638 | DBMET00638 | |
| 0.013 | 0.239 | 0.092 | Fibroblast growth factor 4 antagonist | 0.092 0.012 DBMET00638 | DBMET00638 | |
| 0.019 | 0.248 | 0.174 | CXC chemokine receptor antagonist | 0.174 0.008 DBMET00638 | DBMET00638 | |
| 0.026 | 0.256 | 0.079 | Alpha 2 adrenoreceptor antagonist | 0.079 0.068 DBMET00638 | DBMET00638 | |
| 0.074 | 0.306 | 0.466 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.466 0.009 DBMET00638 | DBMET00638 | |
| 0.015 | 0.25 | 0.057 | Dopamine uptake inhibitor | 0.057 0.041 DBMET00638 | DBMET00638 | |
| 0.038 | 0.274 | 0.097 | Alpha 2c adrenoreceptor antagonist | 0.097 0.069 DBMET00638 | DBMET00638 | |
| 0.038 | 0.275 | 0.14 | Acetylcholine muscarinic antagonist | 0.14 0.05 DBMET00638 | DBMET00638 | |
| 0.008 | 0.246 | 0.082 | Melanocortin 5 antagonist | 0.082 0.009 DBMET00638 | DBMET00638 | |
| 0.022 | 0.261 | 0.062 | CDK1/cyclin B1 inhibitor | 0.062 0.058 DBMET00638 | DBMET00638 | |
| 0.006 | 0.245 | 0.103 | Histamine H3 receptor agonist | 0.103 0.006 DBMET00638 | DBMET00638 | |
| 0.023 | 0.264 | 0.073 | Alpha 2a adrenoreceptor antagonist | 0.073 0.055 DBMET00638 | DBMET00638 | |
| 0.035 | 0.279 | 0.075 | Opioid kappa receptor antagonist | 0.075 0.066 DBMET00638 | DBMET00638 | |
| 0.035 | 0.285 | 0.114 | Cyclin-dependent kinase inhibitor | 0.114 0.078 DBMET00638 | DBMET00638 | |
| 0.007 | 0.258 | 0.025 | 5 Hydroxytryptamine 4 agonist | 0.025 0.015 DBMET00638 | DBMET00638 | |
| 0.121 | 0.373 | 0.419 | Calcium channel activator | 0.419 0.018 DBMET00638 | DBMET00638 | |
| 0.021 | 0.274 | 0.304 | Protein kinase C iota inhibitor | 0.304 0.002 DBMET00638 | DBMET00638 | |
| 0.011 | 0.264 | 0.086 | Opioid delta receptor antagonist | 0.086 0.034 DBMET00638 | DBMET00638 | |
| 0.029 | 0.286 | 0.104 | Opioid antagonist | 0.104 0.045 DBMET00638 | DBMET00638 | |
| 0.021 | 0.281 | 0.084 | Topoisomerase II alpha inhibitor | 0.084 0.05 DBMET00638 | DBMET00638 | |
| 0.018 | 0.281 | 0.071 | Cyclin D1 inhibitor | 0.071 0.027 DBMET00638 | DBMET00638 | |
| 0.01 | 0.273 | 0.062 | Opioid agonist | 0.062 0.028 DBMET00638 | DBMET00638 | |
| 0.029 | 0.293 | 0.114 | Glutamate receptor antagonist | 0.114 0.081 DBMET00638 | DBMET00638 | |
| 0.008 | 0.274 | 0.042 | Opioid mu receptor agonist | 0.042 0.038 DBMET00638 | DBMET00638 | |
| 0.013 | 0.279 | 0.041 | Poly(ADP-ribose) polymerase inhibitor | 0.041 0.038 DBMET00638 | DBMET00638 | |
| 0.013 | 0.283 | 0.05 | Tryptophan 5 hydroxylase inhibitor | 0.05 0.005 DBMET00638 | DBMET00638 | |
| 0.146 | 0.416 | 0.597 | 5 Hydroxytryptamine release inhibitor | 0.597 0.011 DBMET00638 | DBMET00638 | |
| 0.126 | 0.397 | 0.508 | 5 Hydroxytryptamine uptake stimulant | 0.508 0.004 DBMET00638 | DBMET00638 | |
| 0.019 | 0.291 | 0.071 | Glutamate (mGluR group III) antagonist | 0.071 0.009 DBMET00638 | DBMET00638 | |
| 0.016 | 0.289 | 0.213 | Neurotensin receptor antagonist | 0.213 0.006 DBMET00638 | DBMET00638 | |
| 0.004 | 0.278 | 0.055 | GP IIb/IIIa receptor antagonist | 0.055 0.03 DBMET00638 | DBMET00638 | |
| 0.032 | 0.308 | 0.204 | Protein kinase C gamma inhibitor | 0.204 0.013 DBMET00638 | DBMET00638 | |
| 0.013 | 0.289 | 0.076 | Cyclin A1 inhibitor | 0.076 0.017 DBMET00638 | DBMET00638 | |
| 0.004 | 0.281 | 0.07 | Leukotriene A4 hydrolase inhibitor | 0.07 0.011 DBMET00638 | DBMET00638 | |
| 0.067 | 0.345 | 0.222 | Tumour necrosis factor antagonist | 0.222 0.041 DBMET00638 | DBMET00638 | |
| 0.032 | 0.31 | 0.282 | 5 Hydroxytryptamine 3A agonist | 0.282 0.004 DBMET00638 | DBMET00638 | |
| 0.004 | 0.283 | 0.04 | Nicotinic alpha4beta2 receptor agonist | 0.04 0.008 DBMET00638 | DBMET00638 | |
| 0.036 | 0.315 | 0.472 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.472 0.008 DBMET00638 | DBMET00638 | |
| 0.01 | 0.289 | 0.075 | Toll-Like receptor 8 antagonist | 0.075 0.02 DBMET00638 | DBMET00638 | |
| 0.015 | 0.297 | 0.062 | Antibiotic Aminoglycoside-like | 0.062 0.008 DBMET00638 | DBMET00638 | |
| 0.006 | 0.291 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.041 0.004 DBMET00638 | DBMET00638 | |
| 0.039 | 0.326 | 0.114 | mTOR complex 2 inhibitor | 0.114 0.021 DBMET00638 | DBMET00638 | |
| 0.033 | 0.324 | 0.09 | Beta glucuronidase inhibitor | 0.09 0.087 DBMET00638 | DBMET00638 | |
| 0.011 | 0.307 | 0.05 | Nicotinic receptor alpha3 subunit antagonist | 0.05 0.025 DBMET00638 | DBMET00638 | |
| 0.016 | 0.313 | 0.051 | Angiotensin-converting enzyme inhibitor | 0.051 0.046 DBMET00638 | DBMET00638 | |
| 0.034 | 0.332 | 0.222 | CDC-like kinase 4 inhibitor | 0.222 0.057 DBMET00638 | DBMET00638 | |
| 0.012 | 0.316 | 0.064 | Cyclin A2 inhibitor | 0.064 0.043 DBMET00638 | DBMET00638 | |
| 0.029 | 0.334 | 0.749 | GABA C receptor agonist | 0.749 0.002 DBMET00638 | DBMET00638 | |
| 0.027 | 0.333 | 0.25 | Creatine kinase inhibitor | 0.25 0.005 DBMET00638 | DBMET00638 | |
| 0.011 | 0.317 | 0.084 | Opioid mu receptor antagonist | 0.084 0.038 DBMET00638 | DBMET00638 | |
| 0.005 | 0.315 | 0.103 | Glutamate (mGluR1) antagonist | 0.103 0.015 DBMET00638 | DBMET00638 | |
| 0.002 | 0.313 | 0.025 | Kainate receptor 1 antagonist | 0.025 0.012 DBMET00638 | DBMET00638 | |
| 0.043 | 0.355 | 0.18 | TRKC antagonist | 0.18 0.079 DBMET00638 | DBMET00638 | |
| 0.009 | 0.322 | 0.154 | Mannosidase inhibitor | 0.154 0.004 DBMET00638 | DBMET00638 | |
| 0.011 | 0.324 | 0.203 | Growth hormone release inhibitor | 0.203 0.004 DBMET00638 | DBMET00638 | |
| 0.032 | 0.344 | 0.229 | Ribosomal protein S6 kinase inhibitor | 0.229 0.027 DBMET00638 | DBMET00638 | |
| 0.064 | 0.378 | 0.165 | Interferon gamma antagonist | 0.165 0.061 DBMET00638 | DBMET00638 | |
| 0.032 | 0.346 | 0.371 | Thrombolytic | 0.371 0.014 DBMET00638 | DBMET00638 | |
| 0.014 | 0.328 | 0.126 | NMDA receptor antagonist | 0.126 0.033 DBMET00638 | DBMET00638 | |
| 0.008 | 0.325 | 0.173 | Somatostatin 1 antagonist | 0.173 0.004 DBMET00638 | DBMET00638 | |
| 0.02 | 0.337 | 0.229 | Protein kinase (CK1) inhibitor | 0.229 0.032 DBMET00638 | DBMET00638 | |
| 0.013 | 0.33 | 0.104 | Alpha-mannosidase inhibitor | 0.104 0.006 DBMET00638 | DBMET00638 | |
| 0.014 | 0.332 | 0.079 | ZAP-70 protein tyrosine kinase inhibitor | 0.079 0.036 DBMET00638 | DBMET00638 | |
| 0.008 | 0.326 | 0.072 | Acetylcholine M2 receptor antagonist | 0.072 0.035 DBMET00638 | DBMET00638 | |
| 0.003 | 0.321 | 0.028 | Growth hormone releasing factor antagonist | 0.028 0.014 DBMET00638 | DBMET00638 | |
| 0.02 | 0.341 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.034 DBMET00638 | DBMET00638 | |
| 0.018 | 0.34 | 0.13 | Calcium antagonist | 0.13 0.03 DBMET00638 | DBMET00638 | |
| 0.006 | 0.328 | 0.046 | 5 Hydroxytryptamine 6 agonist | 0.046 0.005 DBMET00638 | DBMET00638 | |
| 0.087 | 0.413 | 0.311 | RNA-directed DNA polymerase inhibitor | 0.311 0.029 DBMET00638 | DBMET00638 | |
| 0.004 | 0.331 | 0.041 | Nicotinic alpha3beta4 receptor agonist | 0.041 0.009 DBMET00638 | DBMET00638 | |
| 0.004 | 0.334 | 0.078 | Kainate receptor antagonist | 0.078 0.01 DBMET00638 | DBMET00638 | |
| 0.02 | 0.351 | 0.149 | Cyclin-dependent kinase 2 inhibitor | 0.149 0.038 DBMET00638 | DBMET00638 | |
| 0.009 | 0.341 | 0.057 | 5 Hydroxytryptamine 4 antagonist | 0.057 0.028 DBMET00638 | DBMET00638 | |
| 0.01 | 0.344 | 0.06 | Cyclin A inhibitor | 0.06 0.044 DBMET00638 | DBMET00638 | |
| 0.047 | 0.381 | 0.207 | Platelet antagonist | 0.207 0.096 DBMET00638 | DBMET00638 | |
| 0.014 | 0.348 | 0.054 | Somatostatin 4 agonist | 0.054 0.014 DBMET00638 | DBMET00638 | |
| 0.013 | 0.35 | 0.071 | Dipeptidyl peptidase IV inhibitor | 0.071 0.009 DBMET00638 | DBMET00638 | |
| 0.024 | 0.362 | 0.289 | Somatostatin 1 agonist | 0.289 0.003 DBMET00638 | DBMET00638 | |
| 0.005 | 0.343 | 0.352 | Kinesin antagonist | 0.352 0.002 DBMET00638 | DBMET00638 | |
| 0.005 | 0.343 | 0.352 | Kinesin-like protein 1 inhibitor | 0.352 0.002 DBMET00638 | DBMET00638 | |
| 0.021 | 0.36 | 0.082 | 5 Hydroxytryptamine 5A antagonist | 0.082 0.022 DBMET00638 | DBMET00638 | |
| 0.016 | 0.356 | 0.089 | Dipeptidyl peptidase inhibitor | 0.089 0.011 DBMET00638 | DBMET00638 | |
| 0.005 | 0.35 | 0.044 | NMDA receptor subunit 3A antagonist | 0.044 0.023 DBMET00638 | DBMET00638 | |
| 0.015 | 0.366 | 0.076 | Kainate receptor agonist | 0.076 0.004 DBMET00638 | DBMET00638 | |
| 0.005 | 0.358 | 0.077 | Somatostatin 3 antagonist | 0.077 0.004 DBMET00638 | DBMET00638 | |
| 0.027 | 0.38 | 0.336 | Psychostimulant | 0.336 0.034 DBMET00638 | DBMET00638 | |
| 0.007 | 0.36 | 0.027 | Somatostatin 3 agonist | 0.027 0.005 DBMET00638 | DBMET00638 | |
| 0.011 | 0.364 | 0.045 | MAP3K5 inhibitor | 0.045 0.018 DBMET00638 | DBMET00638 | |
| 0.003 | 0.358 | 0.023 | Complement factor D inhibitor | 0.023 0.005 DBMET00638 | DBMET00638 | |
| 0.013 | 0.371 | 0.081 | Fibroblast growth factor 2 antagonist | 0.081 0.033 DBMET00638 | DBMET00638 | |
| 0.011 | 0.37 | 0.078 | Alpha adrenoreceptor agonist | 0.078 0.039 DBMET00638 | DBMET00638 | |
| 0.096 | 0.456 | 0.168 | MAP kinase kinase 5 inhibitor | 0.168 0.091 DBMET00638 | DBMET00638 | |
| 0.09 | 0.451 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.178 0.008 DBMET00638 | DBMET00638 | |
| 0.028 | 0.39 | 0.131 | Neurotrophic factor | 0.131 0.079 DBMET00638 | DBMET00638 | |
| 0.006 | 0.369 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.013 DBMET00638 | DBMET00638 | |
| 0.074 | 0.437 | 0.184 | MAP-kinase-activated kinase 5 inhibitor | 0.184 0.126 DBMET00638 | DBMET00638 | |
| 0.015 | 0.378 | 0.142 | Dopamine beta hydroxylase inhibitor | 0.142 0.003 DBMET00638 | DBMET00638 | |
| 0.017 | 0.381 | 0.073 | 5 Hydroxytryptamine 5 antagonist | 0.073 0.024 DBMET00638 | DBMET00638 | |
| 0.006 | 0.374 | 0.056 | NMDA receptor subunit 3B antagonist | 0.056 0.021 DBMET00638 | DBMET00638 | |
| 0.021 | 0.392 | 0.077 | Caspase 7 inhibitor | 0.077 0.068 DBMET00638 | DBMET00638 | |
| 0.008 | 0.379 | 0.076 | Carbonic anhydrase I stimulant | 0.076 0.008 DBMET00638 | DBMET00638 | |
| 0.006 | 0.379 | 0.064 | Acetylcholine M3 receptor antagonist | 0.064 0.036 DBMET00638 | DBMET00638 | |
| 0.005 | 0.378 | 0.043 | Protein kinase (CK1) epsilon inhibitor | 0.043 0.021 DBMET00638 | DBMET00638 | |
| 0.029 | 0.405 | 0.277 | Triose-phosphate isomerase inhibitor | 0.277 0.005 DBMET00638 | DBMET00638 | |
| 0.045 | 0.423 | 0.166 | Hexokinase inhibitor | 0.166 0.062 DBMET00638 | DBMET00638 | |
| 0.026 | 0.406 | 0.13 | GABA receptor agonist | 0.13 0.049 DBMET00638 | DBMET00638 | |
| 0.014 | 0.395 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.076 0.004 DBMET00638 | DBMET00638 | |
| 0.009 | 0.39 | 0.083 | Glutamate receptor agonist | 0.083 0.05 DBMET00638 | DBMET00638 | |
| 0.01 | 0.392 | 0.12 | Protein kinase (CK2) inhibitor | 0.12 0.048 DBMET00638 | DBMET00638 | |
| 0.004 | 0.388 | 0.036 | Glutamate (mGluR group II) antagonist | 0.036 0.03 DBMET00638 | DBMET00638 | |
| 0.006 | 0.391 | 0.037 | Protein 30S ribosomal subunit inhibitor | 0.037 0.01 DBMET00638 | DBMET00638 | |
| 0.005 | 0.39 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 DBMET00638 | DBMET00638 | |
| 0.063 | 0.448 | 0.207 | Hypoxia-inducible factor 1 alpha inhibitor | 0.207 0.144 DBMET00638 | DBMET00638 | |
| 0.013 | 0.399 | 0.144 | Purinergic P2X2 antagonist | 0.144 0.013 DBMET00638 | DBMET00638 | |
| 0.016 | 0.402 | 0.089 | Glutamate (mGluR4) antagonist | 0.089 0.007 DBMET00638 | DBMET00638 | |
| 0.01 | 0.397 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.037 0.015 DBMET00638 | DBMET00638 | |
| 0.023 | 0.411 | 0.27 | Clk dual-specificity kinase inhibitor | 0.27 0.047 DBMET00638 | DBMET00638 | |
| 0.035 | 0.423 | 0.132 | NADPH oxidase inhibitor | 0.132 0.069 DBMET00638 | DBMET00638 | |
| 0.009 | 0.398 | 0.177 | Plasmin inhibitor | 0.177 0.008 DBMET00638 | DBMET00638 | |
| 0.003 | 0.393 | 0.076 | Glutamate (mGluR1a) agonist | 0.076 0.004 DBMET00638 | DBMET00638 | |
| 0.004 | 0.395 | 0.056 | Kainate receptor 2 antagonist | 0.056 0.013 DBMET00638 | DBMET00638 | |
| 0.024 | 0.416 | 0.564 | Chelator | 0.564 0.004 DBMET00638 | DBMET00638 | |
| 0.005 | 0.397 | 0.212 | Somatostatin 2 antagonist | 0.212 0.004 DBMET00638 | DBMET00638 | |
| 0.077 | 0.47 | 0.36 | Insulysin inhibitor | 0.36 0.031 DBMET00638 | DBMET00638 | |
| 0.027 | 0.421 | 0.535 | Alpha-N-acetylglucosaminidase inhibitor | 0.535 0.005 DBMET00638 | DBMET00638 | |
| 0.093 | 0.488 | 0.473 | Tyrosine 3 hydroxylase inhibitor | 0.473 0.004 DBMET00638 | DBMET00638 | |
| 0.023 | 0.422 | 0.125 | Keratolytic | 0.125 0.02 DBMET00638 | DBMET00638 | |
| 0.013 | 0.413 | 0.518 | Protein kinase A inhibitor | 0.518 0.004 DBMET00638 | DBMET00638 | |
| 0.01 | 0.412 | 0.552 | Somatostatin 5 agonist | 0.552 0.002 DBMET00638 | DBMET00638 | |
| 0.015 | 0.418 | 0.127 | 5 Hydroxytryptamine 1B agonist | 0.127 0.005 DBMET00638 | DBMET00638 | |
| 0.025 | 0.43 | 0.125 | Glutamate (mGluR6) antagonist | 0.125 0.005 DBMET00638 | DBMET00638 | |
| 0.051 | 0.456 | 0.145 | Factor V inhibitor | 0.145 0.021 DBMET00638 | DBMET00638 | |
| 0.01 | 0.416 | 0.09 | Maillard reaction inhibitor | 0.09 0.021 DBMET00638 | DBMET00638 | |
| 0.016 | 0.424 | 0.239 | Alkylator | 0.239 0.018 DBMET00638 | DBMET00638 | |
| 0.008 | 0.416 | 0.212 | Argininosuccinate synthase inhibitor | 0.212 0.007 DBMET00638 | DBMET00638 | |
| 0.008 | 0.422 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.006 DBMET00638 | DBMET00638 | |
| 0.012 | 0.428 | 0.079 | Glutamate (mGluR8) agonist | 0.079 0.004 DBMET00638 | DBMET00638 | |
| 0.025 | 0.442 | 0.117 | Alpha 2b adrenoreceptor antagonist | 0.117 0.06 DBMET00638 | DBMET00638 | |
| 0.008 | 0.428 | 0.046 | Glutamate (mGluR3) agonist | 0.046 0.006 DBMET00638 | DBMET00638 | |
| 0.009 | 0.429 | 0.058 | Androgen agonist | 0.058 0.044 DBMET00638 | DBMET00638 | |
| 0.008 | 0.429 | 0.053 | Alpha 1 adrenoreceptor agonist | 0.053 0.045 DBMET00638 | DBMET00638 | |
| 0.002 | 0.425 | 0.068 | KiSS-1 receptor antagonist | 0.068 0.003 DBMET00638 | DBMET00638 | |
| 0.014 | 0.438 | 0.071 | CC chemokine 4 receptor antagonist | 0.071 0.01 DBMET00638 | DBMET00638 | |
| 0.007 | 0.433 | 0.041 | Glutamate (mGluR1) agonist | 0.041 0.005 DBMET00638 | DBMET00638 | |
| 0.02 | 0.447 | 0.398 | Aminoacyl-tRNA synthetase inhibitor | 0.398 0.004 DBMET00638 | DBMET00638 | |
| 0.03 | 0.457 | 0.188 | Toll-Like receptor 4 antagonist | 0.188 0.008 DBMET00638 | DBMET00638 | |
| 0.002 | 0.429 | 0.097 | Arginase inhibitor | 0.097 0.004 DBMET00638 | DBMET00638 | |
| 0.025 | 0.455 | 0.206 | Toll-Like receptor antagonist | 0.206 0.028 DBMET00638 | DBMET00638 | |
| 0.015 | 0.445 | 0.143 | Protein kinase B beta inhibitor | 0.143 0.009 DBMET00638 | DBMET00638 | |
| 0.004 | 0.434 | 0.153 | Vascular adhesion protein 1 inhibitor | 0.153 0.004 DBMET00638 | DBMET00638 | |
| 0.021 | 0.455 | 0.243 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.243 0.004 DBMET00638 | DBMET00638 | |
| 0.102 | 0.536 | 0.49 | Caspase 9 stimulant | 0.49 0.064 DBMET00638 | DBMET00638 | |
| 0.021 | 0.455 | 0.253 | UDP-glucose 4-epimerase inhibitor | 0.253 0.013 DBMET00638 | DBMET00638 | |
| 0.005 | 0.44 | 0.044 | Glutamate (mGluR group I) agonist | 0.044 0.038 DBMET00638 | DBMET00638 | |
| 0.006 | 0.441 | 0.151 | Somatostatin 4 antagonist | 0.151 0.004 DBMET00638 | DBMET00638 | |
| 0.026 | 0.462 | 0.257 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.257 0.009 DBMET00638 | DBMET00638 | |
| 0.028 | 0.466 | 0.215 | Nav1.4 sodium channel blocker | 0.215 0.016 DBMET00638 | DBMET00638 | |
| 0.025 | 0.463 | 0.308 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.308 0.029 DBMET00638 | DBMET00638 | |
| 0.012 | 0.451 | 0.076 | 5 Hydroxytryptamine 7 agonist | 0.076 0.015 DBMET00638 | DBMET00638 | |
| 0.015 | 0.455 | 0.133 | Urease inhibitor | 0.133 0.033 DBMET00638 | DBMET00638 | |
| 0.007 | 0.448 | 0.123 | Protein kinase (CK1) delta inhibitor | 0.123 0.071 DBMET00638 | DBMET00638 | |
| 0.004 | 0.449 | 0.169 | Growth hormone releasing factor agonist | 0.169 0.004 DBMET00638 | DBMET00638 | |
| 0.012 | 0.458 | 0.156 | Expectorant | 0.156 0.033 DBMET00638 | DBMET00638 | |
| 0.029 | 0.476 | 0.18 | DOPA decarboxylase inhibitor | 0.18 0.01 DBMET00638 | DBMET00638 | |
| 0.019 | 0.467 | 0.082 | Carbonic anhydrase II stimulant | 0.082 0.009 DBMET00638 | DBMET00638 | |
| 0.005 | 0.454 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | 0.031 0.02 DBMET00638 | DBMET00638 | |
| 0.034 | 0.483 | 0.617 | Aldehyde oxidase inhibitor | 0.617 0.017 DBMET00638 | DBMET00638 | |
| 0.007 | 0.457 | 0.797 | Alcohol oxidase inhibitor | 0.797 0.003 DBMET00638 | DBMET00638 | |
| 0.005 | 0.455 | 0.111 | NMDA 2C receptor antagonist | 0.111 0.013 DBMET00638 | DBMET00638 | |
| 0.004 | 0.455 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.005 DBMET00638 | DBMET00638 | |
| 0.003 | 0.455 | 0.101 | Growth hormone release promoting | 0.101 0.004 DBMET00638 | DBMET00638 | |
| 0.008 | 0.46 | 0.104 | AMPA 4 receptor antagonist | 0.104 0.005 DBMET00638 | DBMET00638 | |
| 0.011 | 0.467 | 0.182 | Protein kinase B alpha inhibitor | 0.182 0.005 DBMET00638 | DBMET00638 | |
| 0.002 | 0.458 | 0.063 | AMPA 1 receptor antagonist | 0.063 0.009 DBMET00638 | DBMET00638 | |
| 0.021 | 0.477 | 0.092 | Factor XII inhibitor | 0.092 0.046 DBMET00638 | DBMET00638 | |
| 0.004 | 0.463 | 0.029 | Nicotinic acid receptor 2 antagonist | 0.029 0.015 DBMET00638 | DBMET00638 | |
| 0.008 | 0.469 | 0.047 | Aminopeptidase N inhibitor | 0.047 0.034 DBMET00638 | DBMET00638 | |
| 0.026 | 0.487 | 0.128 | MAP kinase kinase 7 inhibitor | 0.128 0.004 DBMET00638 | DBMET00638 | |
| 0.009 | 0.471 | 0.343 | Histidine decarboxylase inhibitor | 0.343 0.005 DBMET00638 | DBMET00638 | |
| 0.006 | 0.469 | 0.138 | Protein kinase (CK2) alpha inhibitor | 0.138 0.049 DBMET00638 | DBMET00638 | |
| 0.003 | 0.469 | 0.063 | AMPA 3 receptor antagonist | 0.063 0.005 DBMET00638 | DBMET00638 | |
| 0.005 | 0.471 | 0.084 | NMDA 2A receptor antagonist | 0.084 0.018 DBMET00638 | DBMET00638 | |
| 0.001 | 0.467 | 0.01 | Melatonin 5 antagonist | 0.01 0.009 DBMET00638 | DBMET00638 | |
| 0.037 | 0.504 | 0.136 | Hematopoietic | 0.136 0.017 DBMET00638 | DBMET00638 | |
| 0.002 | 0.47 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DBMET00638 | DBMET00638 | |
| 0.007 | 0.476 | 0.066 | Acetylcholine M5 receptor antagonist | 0.066 0.034 DBMET00638 | DBMET00638 | |
| 0.008 | 0.477 | 0.292 | Check point kinase 1 inhibitor | 0.292 0.005 DBMET00638 | DBMET00638 | |
| 0.085 | 0.555 | 0.43 | Peptidyltransferase inhibitor | 0.43 0.005 DBMET00638 | DBMET00638 | |
| 0.012 | 0.483 | 0.067 | Aminopeptidase microsomal inhibitor | 0.067 0.034 DBMET00638 | DBMET00638 | |
| 0.003 | 0.475 | 0.03 | Cyclin E2 inhibitor | 0.03 0.019 DBMET00638 | DBMET00638 | |
| 0.027 | 0.499 | 0.176 | Heat shock protein 90 antagonist | 0.176 0.051 DBMET00638 | DBMET00638 | |
| 0.02 | 0.495 | 0.194 | Glycine receptor agonist | 0.194 0.004 DBMET00638 | DBMET00638 | |
| 0.009 | 0.484 | 0.278 | Glutamate decarboxylase inhibitor | 0.278 0.004 DBMET00638 | DBMET00638 | |
| 0.012 | 0.488 | 0.284 | Protein kinase (CK1) gamma inhibitor | 0.284 0.021 DBMET00638 | DBMET00638 | |
| 0.009 | 0.487 | 0.077 | Histamine H4 receptor antagonist | 0.077 0.009 DBMET00638 | DBMET00638 | |
| 0.002 | 0.48 | 0.055 | Uridine phosphorylase inhibitor | 0.055 0.007 DBMET00638 | DBMET00638 | |
| 0.007 | 0.487 | 0.089 | GABA B receptor antagonist | 0.089 0.005 DBMET00638 | DBMET00638 | |
| 0.026 | 0.506 | 0.138 | Acetylcholine release stimulant | 0.138 0.025 DBMET00638 | DBMET00638 | |
| 0.038 | 0.52 | 0.17 | Transcription factor STAT6 inhibitor | 0.17 0.013 DBMET00638 | DBMET00638 | |
| 0.006 | 0.49 | 0.133 | Histamine agonist | 0.133 0.005 DBMET00638 | DBMET00638 | |
| 0.054 | 0.539 | 0.433 | Histamine release inhibitor | 0.433 0.058 DBMET00638 | DBMET00638 | |
| 0.039 | 0.526 | 0.205 | 3C-like protease (Human coronavirus) inhibitor | 0.205 0.049 DBMET00638 | DBMET00638 | |
| 0.015 | 0.501 | 0.076 | Macrophage migration inhibitory factor inhibitor | 0.076 0.056 DBMET00638 | DBMET00638 | |
| 0.011 | 0.498 | 0.032 | ATR kinase inhibitor | 0.032 0.024 DBMET00638 | DBMET00638 | |
| 0.009 | 0.497 | 0.149 | Aconitate hydratase inhibitor | 0.149 0.004 DBMET00638 | DBMET00638 | |
| 0.018 | 0.508 | 0.166 | Protein kinase (CK1) gamma 3 inhibitor | 0.166 0.073 DBMET00638 | DBMET00638 | |
| 0.008 | 0.498 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.039 0.018 DBMET00638 | DBMET00638 | |
| 0.017 | 0.508 | 0.083 | Bombesin 2 receptor antagonist | 0.083 0.016 DBMET00638 | DBMET00638 | |
| 0.004 | 0.495 | 0.05 | Sphingosine 1-phosphate receptor agonist | 0.05 0.025 DBMET00638 | DBMET00638 | |
| 0.026 | 0.517 | 0.215 | Antimitotic | 0.215 0.076 DBMET00638 | DBMET00638 | |
| 0.001 | 0.492 | 0.022 | Glutamate (mGluR6) agonist | 0.022 0.004 DBMET00638 | DBMET00638 | |
| 0.001 | 0.493 | 0.014 | Imidazoline I2 receptor antagonist | 0.014 0.005 DBMET00638 | DBMET00638 | |
| 0.003 | 0.495 | 0.046 | Imidazoline I1 receptor antagonist | 0.046 0.004 DBMET00638 | DBMET00638 | |
| 0.004 | 0.496 | 0.093 | NMDA 2 receptor antagonist | 0.093 0.036 DBMET00638 | DBMET00638 | |
| 0.009 | 0.502 | 0.23 | Rho-associated kinase inhibitor | 0.23 0.009 DBMET00638 | DBMET00638 | |
| 0.017 | 0.51 | 0.378 | Protein kinase (CK1) gamma 1 inhibitor | 0.378 0.01 DBMET00638 | DBMET00638 | |
| 0.007 | 0.502 | 0.079 | Membrane dipeptidase inhibitor | 0.079 0.005 DBMET00638 | DBMET00638 | |
| 0.003 | 0.499 | 0.049 | Glycine transporter inhibitor | 0.049 0.032 DBMET00638 | DBMET00638 | |
| 0.015 | 0.514 | 0.195 | Cystathionine beta-synthase inhibitor | 0.195 0.026 DBMET00638 | DBMET00638 | |
| 0.007 | 0.506 | 0.223 | Biliverdin reductase inhibitor | 0.223 0.005 DBMET00638 | DBMET00638 | |
| 0.014 | 0.513 | 0.179 | Mucolytic | 0.179 0.019 DBMET00638 | DBMET00638 | |
| 0.022 | 0.524 | 0.203 | Toll-Like receptor 2 antagonist | 0.203 0.022 DBMET00638 | DBMET00638 | |
| 0.012 | 0.514 | 0.097 | Cyclin-dependent kinase 9 inhibitor | 0.097 0.066 DBMET00638 | DBMET00638 | |
| 0.009 | 0.512 | 0.233 | Inducible nitric-oxide synthase inhibitor | 0.233 0.006 DBMET00638 | DBMET00638 | |
| 0.015 | 0.518 | 0.177 | Toll-Like receptor 9 antagonist | 0.177 0.047 DBMET00638 | DBMET00638 | |
| 0.012 | 0.519 | 0.127 | Glycine receptor antagonist | 0.127 0.015 DBMET00638 | DBMET00638 | |
| 0.008 | 0.515 | 0.116 | MAO A inhibitor | 0.116 0.054 DBMET00638 | DBMET00638 | |
| 0.004 | 0.512 | 0.049 | Urotensin II agonist | 0.049 0.006 DBMET00638 | DBMET00638 | |
| 0.007 | 0.514 | 0.095 | Alpha 2 adrenoreceptor agonist | 0.095 0.016 DBMET00638 | DBMET00638 | |
| 0.004 | 0.515 | 0.073 | Factor VII inhibitor | 0.073 0.009 DBMET00638 | DBMET00638 | |
| 0.038 | 0.551 | 0.186 | Glutamate release inhibitor | 0.186 0.005 DBMET00638 | DBMET00638 | |
| 0.044 | 0.557 | 0.185 | Sphingosine 1-phosphate receptor 5 antagonist | 0.185 0.02 DBMET00638 | DBMET00638 | |
| 0.024 | 0.537 | 0.139 | Granulocyte macrophage colony stimulating factor agonist | 0.139 0.007 DBMET00638 | DBMET00638 | |
| 0.017 | 0.53 | 0.189 | Prolactin inhibitor | 0.189 0.011 DBMET00638 | DBMET00638 | |
| 0.008 | 0.523 | 0.067 | Beta 1 adrenoreceptor antagonist | 0.067 0.029 DBMET00638 | DBMET00638 | |
| 0.003 | 0.519 | 0.021 | Retinoid X beta receptor antagonist | 0.021 0.013 DBMET00638 | DBMET00638 | |
| 0.017 | 0.533 | 0.426 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.426 0.009 DBMET00638 | DBMET00638 | |
| 0.029 | 0.546 | 0.309 | Succinate dehydrogenase inhibitor | 0.309 0.009 DBMET00638 | DBMET00638 | |
| 0.002 | 0.522 | 0.023 | Dopamine autoreceptor agonist | 0.023 0.017 DBMET00638 | DBMET00638 | |
| 0.006 | 0.527 | 0.419 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.419 0.005 DBMET00638 | DBMET00638 | |
| 0.014 | 0.536 | 0.064 | Dihydroorotate oxidase inhibitor | 0.064 0.024 DBMET00638 | DBMET00638 | |
| 0.037 | 0.559 | 0.34 | Phospholipase C inhibitor | 0.34 0.015 DBMET00638 | DBMET00638 | |
| 0.007 | 0.531 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 DBMET00638 | DBMET00638 | |
| 0.008 | 0.531 | 0.518 | Porphobilinogen synthase inhibitor | 0.518 0.003 DBMET00638 | DBMET00638 | |
| 0.006 | 0.531 | 0.108 | Tryptase inhibitor | 0.108 0.005 DBMET00638 | DBMET00638 | |
| 0.025 | 0.551 | 0.156 | DNA methyltransferase I inhibitor | 0.156 0.097 DBMET00638 | DBMET00638 | |
| 0.019 | 0.546 | 0.328 | Anticoagulant | 0.328 0.024 DBMET00638 | DBMET00638 | |
| 0.005 | 0.531 | 0.084 | Fibroblast growth factor 3 antagonist | 0.084 0.045 DBMET00638 | DBMET00638 | |
| 0.018 | 0.545 | 0.352 | GABA C receptor rho-1 antagonist | 0.352 0.003 DBMET00638 | DBMET00638 | |
| 0.029 | 0.557 | 0.153 | Glutamate (mGluR7) agonist | 0.153 0.011 DBMET00638 | DBMET00638 | |
| 0.001 | 0.532 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 DBMET00638 | DBMET00638 | |
| 0.027 | 0.559 | 0.177 | Cyclooxygenase 3 inhibitor | 0.177 0.029 DBMET00638 | DBMET00638 | |
| 0.009 | 0.541 | 0.16 | NMDA receptor agonist | 0.16 0.007 DBMET00638 | DBMET00638 | |
| 0.021 | 0.553 | 0.154 | Heat shock protein 90 alpha antagonist | 0.154 0.082 DBMET00638 | DBMET00638 | |
| 0.043 | 0.579 | 0.146 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.146 0.139 DBMET00638 | DBMET00638 | |
| 0.031 | 0.567 | 0.167 | Melanin inhibitor | 0.167 0.062 DBMET00638 | DBMET00638 | |
| 0.074 | 0.612 | 0.32 | Nitric-oxide synthase stimulant | 0.32 0.008 DBMET00638 | DBMET00638 | |
| 0.018 | 0.557 | 0.554 | Death-associated protein kinase 3 inhibitor | 0.554 0.005 DBMET00638 | DBMET00638 | |
| 0.004 | 0.544 | 0.026 | Bradykinin B2 receptor agonist | 0.026 0.023 DBMET00638 | DBMET00638 | |
| 0.017 | 0.556 | 0.09 | Insulin receptor antagonist | 0.09 0.078 DBMET00638 | DBMET00638 | |
| 0.006 | 0.546 | 0.072 | Syk tyrosine kinase inhibitor | 0.072 0.047 DBMET00638 | DBMET00638 | |
| 0.104 | 0.647 | 0.538 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.538 0.019 DBMET00638 | DBMET00638 | |
| 0.018 | 0.561 | 0.189 | Mannose-6-phosphate isomerase inhibitor | 0.189 0.037 DBMET00638 | DBMET00638 | |
| 0.014 | 0.557 | 0.426 | Ferrochelatase inhibitor | 0.426 0.003 DBMET00638 | DBMET00638 | |
| 0.029 | 0.573 | 0.345 | Interleukin 6 antagonist | 0.345 0.01 DBMET00638 | DBMET00638 | |
| 0.051 | 0.595 | 0.294 | Vasodilator, peripheral | 0.294 0.1 DBMET00638 | DBMET00638 | |
| 0.015 | 0.559 | 0.107 | Alkaline phosphatase inhibitor | 0.107 0.104 DBMET00638 | DBMET00638 | |
| 0.003 | 0.548 | 0.033 | Methionyl aminopeptidase 2 inhibitor | 0.033 0.012 DBMET00638 | DBMET00638 | |
| 0.016 | 0.564 | 0.307 | Glutamate dehydrogenase inhibitor | 0.307 0.005 DBMET00638 | DBMET00638 | |
| 0.014 | 0.563 | 0.07 | Beta 3 adrenoreceptor antagonist | 0.07 0.035 DBMET00638 | DBMET00638 | |
| 0 | 0.55 | 0.014 | Carboxypeptidase B2 inhibitor | 0.014 0.006 DBMET00638 | DBMET00638 | |
| 0.005 | 0.555 | 0.066 | Nav1.7 sodium channel blocker | 0.066 0.049 DBMET00638 | DBMET00638 | |
| 0.005 | 0.556 | 0.094 | Toll-Like receptor 2 agonist | 0.094 0.015 DBMET00638 | DBMET00638 | |
| 0.012 | 0.563 | 0.124 | Sirtuin 1 inhibitor | 0.124 0.013 DBMET00638 | DBMET00638 | |
| 0.022 | 0.575 | 0.271 | NADH dehydrogenase inhibitor | 0.271 0.007 DBMET00638 | DBMET00638 | |
| 0.023 | 0.578 | 0.203 | Amylase inhibitor | 0.203 0.043 DBMET00638 | DBMET00638 | |
| 0.038 | 0.595 | 0.096 | Folate antagonist | 0.096 0.072 DBMET00638 | DBMET00638 | |
| 0.046 | 0.604 | 0.409 | Vasodilator, coronary | 0.409 0.032 DBMET00638 | DBMET00638 | |
| 0.006 | 0.564 | 0.093 | Rho-associated kinase I inhibitor | 0.093 0.036 DBMET00638 | DBMET00638 | |
| 0.003 | 0.562 | 0.045 | Calcium-sensing receptor agonist | 0.045 0.006 DBMET00638 | DBMET00638 | |
| 0.087 | 0.647 | 0.346 | 5 Hydroxytryptamine 3E antagonist | 0.346 0.003 DBMET00638 | DBMET00638 | |
| 0.005 | 0.565 | 0.058 | Dipeptidyl peptidase II inhibitor | 0.058 0.007 DBMET00638 | DBMET00638 | |
| 0.005 | 0.566 | 0.047 | Calcitonin receptor agonist | 0.047 0.018 DBMET00638 | DBMET00638 | |
| 0.004 | 0.566 | 0.068 | Glutamate (mGluR3) antagonist | 0.068 0.006 DBMET00638 | DBMET00638 | |
| 0.016 | 0.578 | 0.072 | Bombesin 3 receptor antagonist | 0.072 0.023 DBMET00638 | DBMET00638 | |
| 0.016 | 0.579 | 0.22 | I kappa B kinase epsilon inhibitor | 0.22 0.055 DBMET00638 | DBMET00638 | |
| 0.013 | 0.577 | 0.202 | Myeloperoxidase inhibitor | 0.202 0.005 DBMET00638 | DBMET00638 | |
| 0.001 | 0.566 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 DBMET00638 | DBMET00638 | |
| 0.002 | 0.567 | 0.104 | Fumarate hydratase inhibitor | 0.104 0.005 DBMET00638 | DBMET00638 | |
| 0.024 | 0.589 | 0.211 | DNA methylase inhibitor | 0.211 0.072 DBMET00638 | DBMET00638 | |
| 0.014 | 0.581 | 0.337 | MAP kinase kinase 2 inhibitor | 0.337 0.024 DBMET00638 | DBMET00638 | |
| 0.017 | 0.584 | 0.149 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.149 0.144 DBMET00638 | DBMET00638 | |
| 0.015 | 0.584 | 0.093 | AMP-activated protein kinase stimulant | 0.093 0.081 DBMET00638 | DBMET00638 | |
| 0.003 | 0.572 | 0.076 | AMPA receptor antagonist | 0.076 0.018 DBMET00638 | DBMET00638 | |
| 0.019 | 0.588 | 0.237 | Spasmolytic | 0.237 0.097 DBMET00638 | DBMET00638 | |
| 0.007 | 0.577 | 0.181 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.181 0.105 DBMET00638 | DBMET00638 | |
| 0.008 | 0.578 | 0.267 | Dyrk kinase inhibitor | 0.267 0.065 DBMET00638 | DBMET00638 | |
| 0.007 | 0.577 | 0.056 | Beta 2 adrenoreceptor antagonist | 0.056 0.028 DBMET00638 | DBMET00638 | |
| 0.02 | 0.591 | 0.075 | MDM2 inhibitor | 0.075 0.027 DBMET00638 | DBMET00638 | |
| 0.035 | 0.607 | 0.207 | CF transmembrane conductance regulator agonist | 0.207 0.018 DBMET00638 | DBMET00638 | |
| 0.007 | 0.58 | 0.05 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 DBMET00638 | DBMET00638 | |
| 0.033 | 0.607 | 0.296 | Antithrombotic | 0.296 0.09 DBMET00638 | DBMET00638 | |
| 0.019 | 0.593 | 0.192 | Electrolyte absorption antagonist | 0.192 0.009 DBMET00638 | DBMET00638 | |
| 0.003 | 0.578 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.012 DBMET00638 | DBMET00638 | |
| 0.005 | 0.581 | 0.027 | Integrin alpha2beta1 antagonist | 0.027 0.017 DBMET00638 | DBMET00638 | |
| 0.011 | 0.588 | 0.24 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.24 0.028 DBMET00638 | DBMET00638 | |
| 0.011 | 0.588 | 0.034 | Vasopressin 1A agonist | 0.034 0.009 DBMET00638 | DBMET00638 | |
| 0.006 | 0.583 | 0.182 | Catalase inhibitor | 0.182 0.019 DBMET00638 | DBMET00638 | |
| 0.005 | 0.584 | 0.057 | Glycine transporter 2 inhibitor | 0.057 0.026 DBMET00638 | DBMET00638 | |
| 0.003 | 0.583 | 0.068 | TRPM8 blocker | 0.068 0.01 DBMET00638 | DBMET00638 | |
| 0.01 | 0.592 | 0.109 | Cholesterol synthesis inhibitor | 0.109 0.076 DBMET00638 | DBMET00638 | |
| 0.01 | 0.591 | 0.097 | Potassium channel intermediate-conductance Ca-activated blocker | 0.097 0.01 DBMET00638 | DBMET00638 | |
| 0.008 | 0.59 | 0.031 | Retinoid X alpha receptor antagonist | 0.031 0.03 DBMET00638 | DBMET00638 | |
| 0.002 | 0.586 | 0.044 | Potassium channel small-conductance Ca-activated activator | 0.044 0.013 DBMET00638 | DBMET00638 | |
| 0.02 | 0.605 | 0.235 | Aldehyde dehydrogenase inhibitor | 0.235 0.021 DBMET00638 | DBMET00638 | |
| 0.003 | 0.589 | 0.043 | Retinoid X alpha receptor agonist | 0.043 0.018 DBMET00638 | DBMET00638 | |
| 0.006 | 0.592 | 0.037 | Integrin alpha2 antagonist | 0.037 0.025 DBMET00638 | DBMET00638 | |
| 0.023 | 0.609 | 0.219 | Amyloid beta aggregation inhibitor | 0.219 0.069 DBMET00638 | DBMET00638 | |
| 0.007 | 0.594 | 0.07 | Beta adrenoreceptor antagonist | 0.07 0.038 DBMET00638 | DBMET00638 | |
| 0.018 | 0.605 | 0.195 | HIV-1 integrase (Overall Integration) inhibitor | 0.195 0.013 DBMET00638 | DBMET00638 | |
| 0.002 | 0.589 | 0.036 | Retinoid X receptor agonist | 0.036 0.025 DBMET00638 | DBMET00638 | |
| 0.016 | 0.604 | 0.285 | Telomerase inhibitor | 0.285 0.007 DBMET00638 | DBMET00638 | |
| 0.012 | 0.603 | 0.134 | Microtubule formation inhibitor | 0.134 0.047 DBMET00638 | DBMET00638 | |
| 0.008 | 0.6 | 0.035 | Retinoid X receptor antagonist | 0.035 0.033 DBMET00638 | DBMET00638 | |
| 0.005 | 0.599 | 0.123 | Monophenol monooxygenase inhibitor | 0.123 0.06 DBMET00638 | DBMET00638 | |
| 0.041 | 0.638 | 0.234 | Neurotensin receptor agonist | 0.234 0.024 DBMET00638 | DBMET00638 | |
| 0.007 | 0.605 | 0.284 | Rho-associated kinase II inhibitor | 0.284 0.006 DBMET00638 | DBMET00638 | |
| 0.003 | 0.602 | 0.147 | Dopamine D5 agonist | 0.147 0.003 DBMET00638 | DBMET00638 | |
| 0.007 | 0.606 | 0.054 | Kallikrein inhibitor | 0.054 0.026 DBMET00638 | DBMET00638 | |
| 0.005 | 0.604 | 0.049 | Carboxypeptidase B inhibitor | 0.049 0.007 DBMET00638 | DBMET00638 | |
| 0.025 | 0.626 | 0.119 | D-Ala-D-Ala ligase inhibitor | 0.119 0.014 DBMET00638 | DBMET00638 | |
| 0.004 | 0.605 | 0.12 | NMDA receptor glycine site agonist | 0.12 0.009 DBMET00638 | DBMET00638 | |
| 0.003 | 0.605 | 0.068 | GABA uptake inhibitor | 0.068 0.007 DBMET00638 | DBMET00638 | |
| 0.07 | 0.673 | 0.177 | Heat shock protein 70 antagonist | 0.177 0.013 DBMET00638 | DBMET00638 | |
| 0.013 | 0.617 | 0.104 | Purinergic P2X1 antagonist | 0.104 0.015 DBMET00638 | DBMET00638 | |
| 0.008 | 0.613 | 0.18 | Aminopeptidase I inhibitor | 0.18 0.009 DBMET00638 | DBMET00638 | |
| 0.003 | 0.609 | 0.051 | Sphingosine 1-phosphate receptor 1 agonist | 0.051 0.019 DBMET00638 | DBMET00638 | |
| 0.004 | 0.611 | 0.048 | Trypsin I inhibitor | 0.048 0.013 DBMET00638 | DBMET00638 | |
| 0.012 | 0.619 | 0.146 | Beta amyloid protein antagonist | 0.146 0.043 DBMET00638 | DBMET00638 | |
| 0.009 | 0.618 | 0.101 | Protein kinase (CK1) gamma 2 inhibitor | 0.101 0.083 DBMET00638 | DBMET00638 | |
| 0.002 | 0.611 | 0.028 | Acetylcholine M4 receptor agonist | 0.028 0.024 DBMET00638 | DBMET00638 | |
| 0.008 | 0.617 | 0.035 | Hedgehog signaling activator | 0.035 0.007 DBMET00638 | DBMET00638 | |
| 0.005 | 0.614 | 0.043 | Melanocortin 1 antagonist | 0.043 0.023 DBMET00638 | DBMET00638 | |
| 0.013 | 0.623 | 0.415 | Cyclin-dependent kinase 7 inhibitor | 0.415 0.005 DBMET00638 | DBMET00638 | |
| 0.004 | 0.615 | 0.216 | Phosphofructokinase-1 inhibitor | 0.216 0.01 DBMET00638 | DBMET00638 | |
| 0.009 | 0.622 | 0.081 | Potassium channel (Tandem pore domain) blocker | 0.081 0.031 DBMET00638 | DBMET00638 | |
| 0.006 | 0.62 | 0.022 | Vasopressin 1 agonist | 0.022 0.016 DBMET00638 | DBMET00638 | |
| 0.009 | 0.623 | 0.056 | Bombesin antagonist | 0.056 0.022 DBMET00638 | DBMET00638 | |
| 0.001 | 0.614 | 0.024 | Aminopeptidase A inhibitor | 0.024 0.008 DBMET00638 | DBMET00638 | |
| 0.005 | 0.619 | 0.189 | MAO inhibitor | 0.189 0.044 DBMET00638 | DBMET00638 | |
| 0.008 | 0.622 | 0.131 | Sodium channel (voltage-gated) blocker | 0.131 0.072 DBMET00638 | DBMET00638 | |
| 0.007 | 0.623 | 0.155 | Alcohol dehydrogenase inhibitor | 0.155 0.019 DBMET00638 | DBMET00638 | |
| 0.002 | 0.619 | 0.146 | Diamine oxidase inhibitor | 0.146 0.003 DBMET00638 | DBMET00638 | |
| 0.014 | 0.631 | 0.123 | Corticotropin releasing factor 2 receptor antagonist | 0.123 0.004 DBMET00638 | DBMET00638 | |
| 0.091 | 0.709 | 0.247 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.247 0.07 DBMET00638 | DBMET00638 | |
| 0.014 | 0.633 | 0.2 | Arachidonic acid antagonist | 0.2 0.033 DBMET00638 | DBMET00638 | |
| 0.003 | 0.622 | 0.104 | Alpha 1d adrenoreceptor agonist | 0.104 0.004 DBMET00638 | DBMET00638 | |
| 0.005 | 0.625 | 0.082 | Glutamate (mGluR1a) antagonist | 0.082 0.008 DBMET00638 | DBMET00638 | |
| 0.002 | 0.623 | 0.019 | Prokineticin receptor 1 antagonist | 0.019 0.008 DBMET00638 | DBMET00638 | |
| 0.01 | 0.632 | 0.138 | CDC-like kinase 1 inhibitor | 0.138 0.079 DBMET00638 | DBMET00638 | |
| 0.016 | 0.639 | 0.13 | Parathyroid hormone antagonist | 0.13 0.002 DBMET00638 | DBMET00638 | |
| 0.008 | 0.632 | 0.248 | LIM domain kinase 1 inhibitor | 0.248 0.039 DBMET00638 | DBMET00638 | |
| 0.002 | 0.627 | 0.016 | CDK2/cyclin A3 inhibitor | 0.016 0.013 DBMET00638 | DBMET00638 | |
| 0.008 | 0.633 | 0.188 | GABA aminotransferase inhibitor | 0.188 0.005 DBMET00638 | DBMET00638 | |
| 0.008 | 0.633 | 0.147 | Phospholipase A2 inhibitor | 0.147 0.077 DBMET00638 | DBMET00638 | |
| 0.001 | 0.627 | 0.025 | Telomerase stimulant | 0.025 0.004 DBMET00638 | DBMET00638 | |
| 0.033 | 0.659 | 0.102 | CC chemokine 5 receptor agonist | 0.102 0.019 DBMET00638 | DBMET00638 | |
| 0.006 | 0.633 | 0.162 | Anesthetic local | 0.162 0.044 DBMET00638 | DBMET00638 | |
| 0.027 | 0.655 | 0.261 | Toll-Like receptor 3 antagonist | 0.261 0.004 DBMET00638 | DBMET00638 | |
| 0.012 | 0.641 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | 0.099 0.059 DBMET00638 | DBMET00638 | |
| 0.01 | 0.64 | 0.145 | Ornithine decarboxylase inhibitor | 0.145 0.012 DBMET00638 | DBMET00638 | |
| 0.014 | 0.643 | 0.05 | CD45 antagonist | 0.05 0.035 DBMET00638 | DBMET00638 | |
| 0.016 | 0.647 | 0.199 | Protein kinase stimulant | 0.199 0.042 DBMET00638 | DBMET00638 | |
| 0.015 | 0.65 | 0.193 | Interleukin 8 antagonist | 0.193 0.014 DBMET00638 | DBMET00638 | |
| 0.002 | 0.637 | 0.226 | Ornithine carbamoyltransferase inhibitor | 0.226 0.006 DBMET00638 | DBMET00638 | |
| 0.003 | 0.639 | 0.039 | Vanilloid 2 agonist | 0.039 0.004 DBMET00638 | DBMET00638 | |
| 0.022 | 0.657 | 0.195 | Photosensitizer | 0.195 0.014 DBMET00638 | DBMET00638 | |
| 0.007 | 0.643 | 0.059 | AICAR transformylase inhibitor | 0.059 0.015 DBMET00638 | DBMET00638 | |
| 0.005 | 0.641 | 0.31 | Check point kinase 2 inhibitor | 0.31 0.006 DBMET00638 | DBMET00638 | |
| 0.001 | 0.637 | 0.021 | Carbonic anhydrase XI inhibitor | 0.021 0.004 DBMET00638 | DBMET00638 | |
| 0.002 | 0.64 | 0.033 | Glutaminyl-peptide cyclotransferase inhibitor | 0.033 0.005 DBMET00638 | DBMET00638 | |
| 0.01 | 0.648 | 0.095 | Cathepsin G inhibitor | 0.095 0.035 DBMET00638 | DBMET00638 | |
| 0.007 | 0.646 | 0.051 | Thymidine kinase inhibitor | 0.051 0.018 DBMET00638 | DBMET00638 | |
| 0.005 | 0.644 | 0.091 | Adrenaline agonist | 0.091 0.044 DBMET00638 | DBMET00638 | |
| 0.01 | 0.65 | 0.09 | Mediator release inhibitor | 0.09 0.082 DBMET00638 | DBMET00638 | |
| 0.001 | 0.641 | 0.043 | Cyclin T1 inhibitor | 0.043 0.003 DBMET00638 | DBMET00638 | |
| 0.012 | 0.654 | 0.101 | Potassium channel (Ca-activated) activator | 0.101 0.055 DBMET00638 | DBMET00638 | |
| 0.002 | 0.643 | 0.072 | Lysine carboxypeptidase inhibitor | 0.072 0.005 DBMET00638 | DBMET00638 | |
| 0.023 | 0.665 | 0.278 | GABA C receptor rho-2 antagonist | 0.278 0.007 DBMET00638 | DBMET00638 | |
| 0.003 | 0.646 | 0.023 | Sodium/hydrogen exchanger inhibitor | 0.023 0.007 DBMET00638 | DBMET00638 | |
| 0.017 | 0.662 | 0.186 | Antiamyloidogenic | 0.186 0.11 DBMET00638 | DBMET00638 | |
| 0.008 | 0.653 | 0.12 | Heat shock protein 90 beta antagonist | 0.12 0.007 DBMET00638 | DBMET00638 | |
| 0.016 | 0.662 | 0.43 | Interleukin antagonist | 0.43 0.027 DBMET00638 | DBMET00638 | |
| 0.017 | 0.663 | 0.343 | Vasodilator | 0.343 0.035 DBMET00638 | DBMET00638 | |
| 0.077 | 0.725 | 0.289 | MAP kinase kinase 3 inhibitor | 0.289 0.01 DBMET00638 | DBMET00638 | |
| 0.039 | 0.688 | 0.466 | Growth hormone agonist | 0.466 0.009 DBMET00638 | DBMET00638 | |
| 0.008 | 0.656 | 0.06 | Lysine-specific demethylase 1A inhibitor | 0.06 0.028 DBMET00638 | DBMET00638 | |
| 0.028 | 0.677 | 0.335 | Cholesterol antagonist | 0.335 0.071 DBMET00638 | DBMET00638 | |
| 0.011 | 0.661 | 0.103 | Caspase 3 inhibitor | 0.103 0.087 DBMET00638 | DBMET00638 | |
| 0.006 | 0.656 | 0.041 | Melatonin receptor 1A agonist | 0.041 0.012 DBMET00638 | DBMET00638 | |
| 0.01 | 0.66 | 0.07 | Neurokinin 2 agonist | 0.07 0.008 DBMET00638 | DBMET00638 | |
| 0.01 | 0.661 | 0.477 | GABA C receptor antagonist | 0.477 0.003 DBMET00638 | DBMET00638 | |
| 0.005 | 0.657 | 0.323 | Phenylalanine 4-hydroxylase inhibitor | 0.323 0.004 DBMET00638 | DBMET00638 | |
| 0.002 | 0.654 | 0.061 | Antimetabolite | 0.061 0.025 DBMET00638 | DBMET00638 | |
| 0.018 | 0.67 | 0.107 | Vanilloid agonist | 0.107 0.027 DBMET00638 | DBMET00638 | |
| 0.012 | 0.665 | 0.116 | Trypsin inhibitor | 0.116 0.012 DBMET00638 | DBMET00638 | |
| 0.007 | 0.661 | 0.241 | Nitric-oxide synthase inhibitor | 0.241 0.005 DBMET00638 | DBMET00638 | |
| 0.026 | 0.681 | 0.32 | Adenylate kinase inhibitor | 0.32 0.006 DBMET00638 | DBMET00638 | |
| 0.003 | 0.66 | 0.061 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.061 0.038 DBMET00638 | DBMET00638 | |
| 0.017 | 0.676 | 0.299 | Transcription factor NF kappa B inhibitor | 0.299 0.094 DBMET00638 | DBMET00638 | |
| 0.003 | 0.662 | 0.039 | Lysophosphatidic acid receptor 1 agonist | 0.039 0.006 DBMET00638 | DBMET00638 | |
| 0.017 | 0.676 | 0.131 | Nav1.3 sodium channel blocker | 0.131 0.062 DBMET00638 | DBMET00638 | |
| 0.021 | 0.681 | 0.184 | Cardiotonic | 0.184 0.135 DBMET00638 | DBMET00638 | |
| 0.003 | 0.665 | 0.082 | Complement C3a chemotactic receptor antagonist | 0.082 0.013 DBMET00638 | DBMET00638 | |
| 0.009 | 0.674 | 0.041 | Potassium channel small-conductance Ca-activated blocker | 0.041 0.038 DBMET00638 | DBMET00638 | |
| 0.008 | 0.672 | 0.16 | MAP kinase kinase 1 inhibitor | 0.16 0.013 DBMET00638 | DBMET00638 | |
| 0.004 | 0.669 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.118 0.017 DBMET00638 | DBMET00638 | |
| 0.005 | 0.67 | 0.052 | HCV NS3/NS4A protease inhibitor | 0.052 0.029 DBMET00638 | DBMET00638 | |
| 0.007 | 0.675 | 0.06 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.06 0.03 DBMET00638 | DBMET00638 | |
| 0.007 | 0.675 | 0.169 | MAP kinase kinase inhibitor | 0.169 0.042 DBMET00638 | DBMET00638 | |
| 0.012 | 0.68 | 0.567 | I kappa B kinase 1 inhibitor | 0.567 0.003 DBMET00638 | DBMET00638 | |
| 0.007 | 0.676 | 0.102 | Plasminogen activator inhibitor | 0.102 0.015 DBMET00638 | DBMET00638 | |
| 0.005 | 0.675 | 0.029 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.029 0.016 DBMET00638 | DBMET00638 | |
| 0.02 | 0.691 | 0.094 | Phosphodiesterase 6D inhibitor | 0.094 0.066 DBMET00638 | DBMET00638 | |
| 0.008 | 0.68 | 0.166 | Falcipain 3 inhibitor | 0.166 0.03 DBMET00638 | DBMET00638 | |
| 0.007 | 0.679 | 0.136 | Carbonic anhydrase stimulant | 0.136 0.012 DBMET00638 | DBMET00638 | |
| 0.003 | 0.677 | 0.11 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.11 0.038 DBMET00638 | DBMET00638 | |
| 0.013 | 0.686 | 0.245 | Aminopeptidase B inhibitor | 0.245 0.013 DBMET00638 | DBMET00638 | |
| 0.019 | 0.693 | 0.359 | Histone deacetylase SIRT1 inhibitor | 0.359 0.005 DBMET00638 | DBMET00638 | |
| 0.009 | 0.686 | 0.174 | Sphingosine 1-phosphate receptor 2 antagonist | 0.174 0.018 DBMET00638 | DBMET00638 | |
| 0.007 | 0.684 | 0.041 | Adenosine uptake inhibitor | 0.041 0.01 DBMET00638 | DBMET00638 | |
| 0.002 | 0.679 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.012 DBMET00638 | DBMET00638 | |
| 0.001 | 0.679 | 0.05 | Carbonic anhydrase X inhibitor | 0.05 0.003 DBMET00638 | DBMET00638 | |
| 0.001 | 0.679 | 0.05 | Carbonic anhydrase VIII inhibitor | 0.05 0.003 DBMET00638 | DBMET00638 | |
| 0.025 | 0.703 | 0.281 | Transcription factor STAT inhibitor | 0.281 0.067 DBMET00638 | DBMET00638 | |
| 0.007 | 0.686 | 0.362 | Anesthetic general | 0.362 0.022 DBMET00638 | DBMET00638 | |
| 0.019 | 0.698 | 0.077 | Transcription factor RelA inhibitor | 0.077 0.02 DBMET00638 | DBMET00638 | |
| 0.013 | 0.692 | 0.142 | Anabolic | 0.142 0.023 DBMET00638 | DBMET00638 | |
| 0.014 | 0.695 | 0.199 | Focal adhesion kinase 2 inhibitor | 0.199 0.07 DBMET00638 | DBMET00638 | |
| 0.005 | 0.69 | 0.064 | Lysophosphatidic acid 3 receptor antagonist | 0.064 0.019 DBMET00638 | DBMET00638 | |
| 0.004 | 0.69 | 0.047 | Antidiuretic hormone antagonist | 0.047 0.024 DBMET00638 | DBMET00638 | |
| 0.001 | 0.688 | 0.016 | Thromboxane A2 agonist | 0.016 0.009 DBMET00638 | DBMET00638 | |
| 0 | 0.688 | 0.025 | Lysophosphatidic acid receptor 3 agonist | 0.025 0.004 DBMET00638 | DBMET00638 | |
| 0.017 | 0.705 | 0.348 | Carbonic anhydrase XV inhibitor | 0.348 0.005 DBMET00638 | DBMET00638 | |
| 0.003 | 0.691 | 0.052 | Carbonic anhydrase VII inhibitor | 0.052 0.026 DBMET00638 | DBMET00638 | |
| 0.002 | 0.69 | 0.11 | Endothelial nitric-oxide synthase inhibitor | 0.11 0.004 DBMET00638 | DBMET00638 | |
| 0.008 | 0.698 | 0.048 | Aldosterone antagonist | 0.048 0.032 DBMET00638 | DBMET00638 | |
| 0.004 | 0.694 | 0.156 | Urokinase inhibitor | 0.156 0.006 DBMET00638 | DBMET00638 | |
| 0.002 | 0.692 | 0.042 | Methionyl aminopeptidase 1 inhibitor | 0.042 0.01 DBMET00638 | DBMET00638 | |
| 0.009 | 0.7 | 0.171 | GABA B receptor agonist | 0.171 0.004 DBMET00638 | DBMET00638 | |
| 0.024 | 0.714 | 0.075 | Calcium channel P-type blocker | 0.075 0.02 DBMET00638 | DBMET00638 | |
| 0.012 | 0.703 | 0.076 | Phosphodiesterase VI inhibitor | 0.076 0.049 DBMET00638 | DBMET00638 | |
| 0.005 | 0.698 | 0.109 | Factor VIIa inhibitor | 0.109 0.011 DBMET00638 | DBMET00638 | |
| 0.012 | 0.706 | 0.205 | Cathepsin H inhibitor | 0.205 0.021 DBMET00638 | DBMET00638 | |
| 0.004 | 0.699 | 0.099 | MAP kinase kinase kinase inhibitor | 0.099 0.068 DBMET00638 | DBMET00638 | |
| 0.013 | 0.709 | 0.237 | Carbonic anhydrase VI inhibitor | 0.237 0.009 DBMET00638 | DBMET00638 | |
| 0.005 | 0.703 | 0.149 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.149 0.004 DBMET00638 | DBMET00638 | |
| 0.002 | 0.7 | 0.08 | Geranyltranstransferase inhibitor | 0.08 0.005 DBMET00638 | DBMET00638 | |
| 0.003 | 0.702 | 0.058 | Cathepsin L inhibitor | 0.058 0.04 DBMET00638 | DBMET00638 | |
| 0.004 | 0.705 | 0.053 | Prolyl endopeptidase inhibitor | 0.053 0.033 DBMET00638 | DBMET00638 | |
| 0.001 | 0.703 | 0.049 | Alpha 2a adrenoreceptor agonist | 0.049 0.004 DBMET00638 | DBMET00638 | |
| 0.01 | 0.714 | 0.057 | Phosphodiesterase 1A inhibitor | 0.057 0.048 DBMET00638 | DBMET00638 | |
| 0.005 | 0.709 | 0.093 | CDC7 inhibitor | 0.093 0.027 DBMET00638 | DBMET00638 | |
| 0.015 | 0.72 | 0.149 | TRPA1 agonist | 0.149 0.032 DBMET00638 | DBMET00638 | |
| 0.004 | 0.715 | 0.052 | Plasmepsin II inhibitor | 0.052 0.016 DBMET00638 | DBMET00638 | |
| 0.038 | 0.75 | 0.504 | Death-associated protein kinase 2 inhibitor | 0.504 0.003 DBMET00638 | DBMET00638 | |
| 0.005 | 0.716 | 0.131 | Cytidine deaminase inhibitor | 0.131 0.09 DBMET00638 | DBMET00638 | |
| 0.002 | 0.714 | 0.067 | Dihydropteroate synthase inhibitor | 0.067 0.009 DBMET00638 | DBMET00638 | |
| 0.003 | 0.715 | 0.078 | Factor X inhibitor | 0.078 0.014 DBMET00638 | DBMET00638 | |
| 0.002 | 0.717 | 0.034 | Epoxide hydrolase 1 inhibitor | 0.034 0.017 DBMET00638 | DBMET00638 | |
| 0.015 | 0.73 | 0.267 | Adenylate cyclase stimulant | 0.267 0.004 DBMET00638 | DBMET00638 | |
| 0.002 | 0.718 | 0.022 | Prostaglandin F2 alpha agonist | 0.022 0.017 DBMET00638 | DBMET00638 | |
| 0.004 | 0.719 | 0.154 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.154 0.008 DBMET00638 | DBMET00638 | |
| 0.003 | 0.719 | 0.221 | Acyl-CoA dehydrogenase inhibitor | 0.221 0.004 DBMET00638 | DBMET00638 | |
| 0.002 | 0.718 | 0.039 | Cathepsin L1 inhibitor | 0.039 0.028 DBMET00638 | DBMET00638 | |
| 0.004 | 0.721 | 0.106 | Growth hormone secretagogue receptor antagonist | 0.106 0.006 DBMET00638 | DBMET00638 | |
| 0.035 | 0.751 | 0.618 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.618 0.004 DBMET00638 | DBMET00638 | |
| 0.001 | 0.719 | 0.053 | 5 Hydroxytryptamine 1D agonist | 0.053 0.009 DBMET00638 | DBMET00638 | |
| 0.027 | 0.745 | 0.148 | MAP kinase 3 inhibitor | 0.148 0.071 DBMET00638 | DBMET00638 | |
| 0.021 | 0.739 | 0.193 | Histone acetyltransferase inhibitor | 0.193 0.079 DBMET00638 | DBMET00638 | |
| 0.006 | 0.725 | 0.077 | Cytokine production stimulant | 0.077 0.005 DBMET00638 | DBMET00638 | |
| 0.004 | 0.725 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.004 DBMET00638 | DBMET00638 | |
| 0.003 | 0.725 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.017 DBMET00638 | DBMET00638 | |
| 0.013 | 0.738 | 0.255 | Transcription factor STAT3 inhibitor | 0.255 0.079 DBMET00638 | DBMET00638 | |
| 0.003 | 0.728 | 0.084 | Carbonic anhydrase XIV inhibitor | 0.084 0.015 DBMET00638 | DBMET00638 | |
| 0.006 | 0.731 | 0.071 | Adenosine deaminase inhibitor | 0.071 0.013 DBMET00638 | DBMET00638 | |
| 0.003 | 0.729 | 0.034 | Thymidine phosphorylase inhibitor | 0.034 0.009 DBMET00638 | DBMET00638 | |
| 0.002 | 0.73 | 0.033 | Acid ceramidase inhibitor | 0.033 0.006 DBMET00638 | DBMET00638 | |
| 0.017 | 0.745 | 0.571 | Peroxidase inhibitor | 0.571 0.005 DBMET00638 | DBMET00638 | |
| 0.004 | 0.733 | 0.068 | Bombesin 1 receptor antagonist | 0.068 0.005 DBMET00638 | DBMET00638 | |
| 0.005 | 0.735 | 0.128 | Sodium channel blocker | 0.128 0.076 DBMET00638 | DBMET00638 | |
| 0.004 | 0.734 | 0.079 | Sphingosine kinase inhibitor | 0.079 0.017 DBMET00638 | DBMET00638 | |
| 0.002 | 0.734 | 0.176 | Carbonic anhydrase VB inhibitor | 0.176 0.006 DBMET00638 | DBMET00638 | |
| 0.005 | 0.739 | 0.059 | Glutamate (mGluR group III) agonist | 0.059 0.019 DBMET00638 | DBMET00638 | |
| 0.013 | 0.747 | 0.163 | Antipruritic | 0.163 0.081 DBMET00638 | DBMET00638 | |
| 0.003 | 0.737 | 0.06 | Dihydrofolate reductase inhibitor | 0.06 0.01 DBMET00638 | DBMET00638 | |
| 0.003 | 0.737 | 0.051 | Peptide deformylase inhibitor | 0.051 0.009 DBMET00638 | DBMET00638 | |
| 0.007 | 0.742 | 0.088 | Glucose-6-phosphate isomerase inhibitor | 0.088 0.007 DBMET00638 | DBMET00638 | |
| 0.012 | 0.747 | 0.313 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.313 0.02 DBMET00638 | DBMET00638 | |
| 0.004 | 0.74 | 0.088 | Secretase beta inhibitor | 0.088 0.027 DBMET00638 | DBMET00638 | |
| 0.005 | 0.741 | 0.051 | Potassium channel (ATP-sensitive) activator | 0.051 0.028 DBMET00638 | DBMET00638 | |
| 0.005 | 0.741 | 0.053 | Potassium channel (Inward rectifier) activator | 0.053 0.029 DBMET00638 | DBMET00638 | |
| 0.002 | 0.74 | 0.062 | Thymidylate synthase inhibitor | 0.062 0.015 DBMET00638 | DBMET00638 | |
| 0.014 | 0.751 | 0.261 | Carbonic anhydrase III inhibitor | 0.261 0.008 DBMET00638 | DBMET00638 | |
| 0.002 | 0.741 | 0.035 | MAP3K8 inhibitor | 0.035 0.01 DBMET00638 | DBMET00638 | |
| 0.002 | 0.742 | 0.027 | LFA antagonist | 0.027 0.02 DBMET00638 | DBMET00638 | |
| 0.003 | 0.743 | 0.044 | Benzodiazepine antagonist | 0.044 0.041 DBMET00638 | DBMET00638 | |
| 0.001 | 0.741 | 0.057 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.057 0.008 DBMET00638 | DBMET00638 | |
| 0 | 0.742 | 0.007 | CC chemokine 6 receptor agonist | 0.007 0.004 DBMET00638 | DBMET00638 | |
| 0.004 | 0.752 | 0.145 | Carbonic anhydrase VA inhibitor | 0.145 0.012 DBMET00638 | DBMET00638 | |
| 0.003 | 0.751 | 0.243 | Carbamoyl phosphate synthetase inhibitor | 0.243 0.006 DBMET00638 | DBMET00638 | |
| 0.012 | 0.76 | 0.154 | Sphingosine 1-phosphate receptor 4 antagonist | 0.154 0.03 DBMET00638 | DBMET00638 | |
| 0.003 | 0.752 | 0.05 | Sphingosine kinase 1 inhibitor | 0.05 0.017 DBMET00638 | DBMET00638 | |
| 0.001 | 0.75 | 0.025 | Alpha 2c adrenoreceptor agonist | 0.025 0.007 DBMET00638 | DBMET00638 | |
| 0.003 | 0.754 | 0.067 | Neutrophil collagenase inhibitor | 0.067 0.042 DBMET00638 | DBMET00638 | |
| 0.001 | 0.753 | 0.021 | CXC chemokine 4 receptor agonist | 0.021 0.005 DBMET00638 | DBMET00638 | |
| 0.011 | 0.764 | 0.188 | Nav1.2 sodium channel blocker | 0.188 0.039 DBMET00638 | DBMET00638 | |
| 0.011 | 0.764 | 0.082 | Phosphodiesterase I inhibitor | 0.082 0.073 DBMET00638 | DBMET00638 | |
| 0 | 0.755 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.004 DBMET00638 | DBMET00638 | |
| 0.021 | 0.775 | 0.115 | Estrogen-related receptor beta agonist | 0.115 0.012 DBMET00638 | DBMET00638 | |
| 0.002 | 0.757 | 0.064 | Adenosine A2a receptor antagonist | 0.064 0.041 DBMET00638 | DBMET00638 | |
| 0.006 | 0.762 | 0.093 | Protease 3C (Human rhinovirus) inhibitor | 0.093 0.019 DBMET00638 | DBMET00638 | |
| 0.017 | 0.773 | 0.181 | Vanilloid 1 agonist | 0.181 0.018 DBMET00638 | DBMET00638 | |
| 0.005 | 0.761 | 0.564 | Protein kinase B gamma inhibitor | 0.564 0.003 DBMET00638 | DBMET00638 | |
| 0.008 | 0.769 | 0.328 | Immunostimulant | 0.328 0.071 DBMET00638 | DBMET00638 | |
| 0.002 | 0.763 | 0.144 | MAO B inhibitor | 0.144 0.039 DBMET00638 | DBMET00638 | |
| 0.011 | 0.772 | 0.6 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.6 0.004 DBMET00638 | DBMET00638 | |
| 0.011 | 0.772 | 0.174 | Sphingomyelinase inhibitor | 0.174 0.016 DBMET00638 | DBMET00638 | |
| 0.002 | 0.765 | 0.044 | Myristoyl transferase inhibitor | 0.044 0.005 DBMET00638 | DBMET00638 | |
| 0.007 | 0.77 | 0.198 | Carbonic anhydrase XIII inhibitor | 0.198 0.014 DBMET00638 | DBMET00638 | |
| 0.012 | 0.775 | 0.184 | CDC-like kinase 3 inhibitor | 0.184 0.009 DBMET00638 | DBMET00638 | |
| 0.003 | 0.767 | 0.039 | Factor Xa inhibitor | 0.039 0.038 DBMET00638 | DBMET00638 | |
| 0.004 | 0.769 | 0.072 | Sphingosine 1-phosphate receptor 3 antagonist | 0.072 0.024 DBMET00638 | DBMET00638 | |
| 0.012 | 0.779 | 0.22 | Cyclic AMP phosphodiesterase inhibitor | 0.22 0.08 DBMET00638 | DBMET00638 | |
| 0.016 | 0.783 | 0.105 | Kallikrein 1 inhibitor | 0.105 0.011 DBMET00638 | DBMET00638 | |
| 0.003 | 0.77 | 0.16 | Carbonic anhydrase V inhibitor | 0.16 0.012 DBMET00638 | DBMET00638 | |
| 0.002 | 0.77 | 0.024 | Protease (Human cytomegalovirus) inhibitor | 0.024 0.012 DBMET00638 | DBMET00638 | |
| 0.005 | 0.774 | 0.174 | Aryl hydrocarbon receptor agonist | 0.174 0.118 DBMET00638 | DBMET00638 | |
| 0.002 | 0.771 | 0.022 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 DBMET00638 | DBMET00638 | |
| 0.021 | 0.791 | 0.322 | Immunomodulator | 0.322 0.071 DBMET00638 | DBMET00638 | |
| 0.002 | 0.773 | 0.038 | Angiotensin AT1 receptor antagonist | 0.038 0.037 DBMET00638 | DBMET00638 | |
| 0.002 | 0.774 | 0.064 | Adenosine A2 receptor antagonist | 0.064 0.045 DBMET00638 | DBMET00638 | |
| 0.007 | 0.78 | 0.204 | Cyclin-dependent kinase 8 inhibitor | 0.204 0.033 DBMET00638 | DBMET00638 | |
| 0.004 | 0.776 | 0.097 | Sphingosine kinase 2 inhibitor | 0.097 0.009 DBMET00638 | DBMET00638 | |
| 0.002 | 0.775 | 0.055 | Cannabinoid CB1 receptor agonist | 0.055 0.048 DBMET00638 | DBMET00638 | |
| 0.006 | 0.779 | 0.103 | Interferon inducer | 0.103 0.011 DBMET00638 | DBMET00638 | |
| 0.028 | 0.801 | 0.63 | GABA C receptor rho-3 antagonist | 0.63 0.005 DBMET00638 | DBMET00638 | |
| 0.005 | 0.778 | 0.064 | Glucosylceramidase inhibitor | 0.064 0.027 DBMET00638 | DBMET00638 | |
| 0.005 | 0.78 | 0.139 | Thrombin inhibitor | 0.139 0.013 DBMET00638 | DBMET00638 | |
| 0.007 | 0.782 | 0.201 | Histamine N-methyltransferase inhibitor | 0.201 0.005 DBMET00638 | DBMET00638 | |
| 0.003 | 0.778 | 0.067 | Oxytocin agonist | 0.067 0.012 DBMET00638 | DBMET00638 | |
| 0.003 | 0.779 | 0.123 | Protease activated receptor 1 antagonist | 0.123 0.01 DBMET00638 | DBMET00638 | |
| 0.008 | 0.785 | 0.181 | Nav1.6 sodium channel blocker | 0.181 0.028 DBMET00638 | DBMET00638 | |
| 0.004 | 0.782 | 0.066 | Protease activated receptor antagonist | 0.066 0.038 DBMET00638 | DBMET00638 | |
| 0.005 | 0.786 | 0.215 | Anticonvulsant | 0.215 0.073 DBMET00638 | DBMET00638 | |
| 0.008 | 0.791 | 0.121 | Nav1.5 sodium channel blocker | 0.121 0.053 DBMET00638 | DBMET00638 | |
| 0.001 | 0.785 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.015 DBMET00638 | DBMET00638 | |
| 0.001 | 0.785 | 0.109 | Phosphoglycerate kinase inhibitor | 0.109 0.006 DBMET00638 | DBMET00638 | |
| 0.007 | 0.795 | 0.177 | Neuropeptide Y1 antagonist | 0.177 0.032 DBMET00638 | DBMET00638 | |
| 0.005 | 0.794 | 0.041 | Potassium channel Kv1.1 blocker | 0.041 0.021 DBMET00638 | DBMET00638 | |
| 0.014 | 0.803 | 0.225 | Neurotrophic factor enhancer | 0.225 0.055 DBMET00638 | DBMET00638 | |
| 0.003 | 0.794 | 0.035 | Glutamate (mGluR4) agonist | 0.035 0.021 DBMET00638 | DBMET00638 | |
| 0.006 | 0.798 | 0.14 | Histamine H2 receptor antagonist | 0.14 0.012 DBMET00638 | DBMET00638 | |
| 0.005 | 0.797 | 0.128 | Interferon agonist | 0.128 0.015 DBMET00638 | DBMET00638 | |
| 0.004 | 0.803 | 0.064 | Potassium channel (ATP-sensitive) blocker | 0.064 0.051 DBMET00638 | DBMET00638 | |
| 0.001 | 0.8 | 0.019 | Neurokinin 1 agonist | 0.019 0.015 DBMET00638 | DBMET00638 | |
| 0.004 | 0.803 | 0.126 | Epithelial sodium channel blocker | 0.126 0.004 DBMET00638 | DBMET00638 | |
| 0.018 | 0.818 | 0.279 | Gastrin inhibitor | 0.279 0.049 DBMET00638 | DBMET00638 | |
| 0.005 | 0.806 | 0.083 | Neuropeptide Y antagonist | 0.083 0.054 DBMET00638 | DBMET00638 | |
| 0.004 | 0.805 | 0.202 | Diuretic | 0.202 0.043 DBMET00638 | DBMET00638 | |
| 0.001 | 0.803 | 0.048 | Carbonic anhydrase XII inhibitor | 0.048 0.039 DBMET00638 | DBMET00638 | |
| 0.005 | 0.807 | 0.108 | I kappa B kinase 2 inhibitor | 0.108 0.01 DBMET00638 | DBMET00638 | |
| 0.004 | 0.806 | 0.115 | Adenylate cyclase 1 inhibitor | 0.115 0.003 DBMET00638 | DBMET00638 | |
| 0.003 | 0.807 | 0.025 | ICAM 1 antagonist | 0.025 0.011 DBMET00638 | DBMET00638 | |
| 0.001 | 0.807 | 0.015 | Vitamin D receptor agonist | 0.015 0.014 DBMET00638 | DBMET00638 | |
| 0.004 | 0.811 | 0.029 | Glucosylceramidase stimulant | 0.029 0.014 DBMET00638 | DBMET00638 | |
| 0.001 | 0.81 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 DBMET00638 | DBMET00638 | |
| 0.008 | 0.822 | 0.265 | Adenylate cyclase inhibitor | 0.265 0.017 DBMET00638 | DBMET00638 | |
| 0.004 | 0.822 | 0.143 | I kappa B kinase inhibitor | 0.143 0.018 DBMET00638 | DBMET00638 | |
| 0.003 | 0.821 | 0.046 | Factor XIIIa inhibitor | 0.046 0.018 DBMET00638 | DBMET00638 | |
| 0.001 | 0.822 | 0.055 | Sirtuin 2 inhibitor | 0.055 0.011 DBMET00638 | DBMET00638 | |
| 0.003 | 0.825 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.034 DBMET00638 | DBMET00638 | |
| 0.001 | 0.824 | 0.051 | Fructose-1,6-bisphosphatase inhibitor | 0.051 0.024 DBMET00638 | DBMET00638 | |
| 0.01 | 0.833 | 0.122 | Exportin-1 inhibitor | 0.122 0.004 DBMET00638 | DBMET00638 | |
| 0.014 | 0.84 | 0.289 | Neuropeptide Y2 antagonist | 0.289 0.025 DBMET00638 | DBMET00638 | |
| 0.001 | 0.828 | 0.039 | Histamine H4 receptor agonist | 0.039 0.005 DBMET00638 | DBMET00638 | |
| 0.002 | 0.83 | 0.026 | Factor XIII inhibitor | 0.026 0.006 DBMET00638 | DBMET00638 | |
| 0.004 | 0.833 | 0.232 | CYP2A6 inhibitor | 0.232 0.005 DBMET00638 | DBMET00638 | |
| 0.012 | 0.842 | 0.159 | Lanosterol 14 alpha demethylase inhibitor | 0.159 0.009 DBMET00638 | DBMET00638 | |
| 0.001 | 0.831 | 0.02 | Purinergic P2Y1 agonist | 0.02 0.007 DBMET00638 | DBMET00638 | |
| 0 | 0.831 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET00638 | DBMET00638 | |
| 0.009 | 0.842 | 0.076 | Immunoglobulin Fc receptor antagonist | 0.076 0.008 DBMET00638 | DBMET00638 | |
| 0 | 0.833 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 DBMET00638 | DBMET00638 | |
| 0.007 | 0.841 | 0.103 | Glutathione S-transferase inhibitor | 0.103 0.034 DBMET00638 | DBMET00638 | |
| 0.003 | 0.837 | 0.122 | Sphingosine 1-phosphate receptor 4 agonist | 0.122 0.016 DBMET00638 | DBMET00638 | |
| 0.009 | 0.845 | 0.097 | Bile acid receptor antagonist | 0.097 0.056 DBMET00638 | DBMET00638 | |
| 0.011 | 0.849 | 0.184 | ATPase inhibitor | 0.184 0.053 DBMET00638 | DBMET00638 | |
| 0.004 | 0.842 | 0.228 | Calpain inhibitor | 0.228 0.086 DBMET00638 | DBMET00638 | |
| 0.003 | 0.843 | 0.07 | Beta 2 adrenoreceptor agonist | 0.07 0.02 DBMET00638 | DBMET00638 | |
| 0.008 | 0.851 | 0.103 | Vanilloid 4 agonist | 0.103 0.014 DBMET00638 | DBMET00638 | |
| 0.005 | 0.849 | 0.181 | Non-steroidal antiinflammatory agent | 0.181 0.086 DBMET00638 | DBMET00638 | |
| 0.004 | 0.85 | 0.087 | Adenosine A3 receptor antagonist | 0.087 0.035 DBMET00638 | DBMET00638 | |
| 0.005 | 0.852 | 0.239 | Histone deacetylase class III inhibitor | 0.239 0.011 DBMET00638 | DBMET00638 | |
| 0.005 | 0.853 | 0.043 | Thrombin receptor antagonist | 0.043 0.011 DBMET00638 | DBMET00638 | |
| 0.002 | 0.851 | 0.086 | Histamine H1 receptor agonist | 0.086 0.003 DBMET00638 | DBMET00638 | |
| 0.004 | 0.855 | 0.087 | Gastric antisecretory | 0.087 0.083 DBMET00638 | DBMET00638 | |
| 0.007 | 0.859 | 0.168 | Thiol protease inhibitor | 0.168 0.055 DBMET00638 | DBMET00638 | |
| 0.002 | 0.857 | 0.072 | Adenosine A1 receptor antagonist | 0.072 0.032 DBMET00638 | DBMET00638 | |
| 0.001 | 0.86 | 0.065 | Ribonucleotide reductase inhibitor | 0.065 0.034 DBMET00638 | DBMET00638 | |
| 0.004 | 0.863 | 0.04 | Complement factor 1s inhibitor | 0.04 0.004 DBMET00638 | DBMET00638 | |
| 0.001 | 0.861 | 0.024 | CXC chemokine 2 receptor antagonist | 0.024 0.023 DBMET00638 | DBMET00638 | |
| 0.001 | 0.862 | 0.055 | Carbonic anhydrase I inhibitor | 0.055 0.039 DBMET00638 | DBMET00638 | |
| 0.007 | 0.868 | 0.123 | Neuropeptide agonist | 0.123 0.021 DBMET00638 | DBMET00638 | |
| 0.002 | 0.863 | 0.038 | Toll-Like receptor 8 agonist | 0.038 0.004 DBMET00638 | DBMET00638 | |
| 0.002 | 0.866 | 0.049 | Adenosine A2b receptor antagonist | 0.049 0.035 DBMET00638 | DBMET00638 | |
| 0.005 | 0.872 | 0.302 | 15-Lipoxygenase inhibitor | 0.302 0.131 DBMET00638 | DBMET00638 | |
| 0.001 | 0.869 | 0.064 | Carbonic anhydrase inhibitor | 0.064 0.043 DBMET00638 | DBMET00638 | |
| 0.001 | 0.87 | 0.055 | Carbonic anhydrase II inhibitor | 0.055 0.039 DBMET00638 | DBMET00638 | |
| 0.004 | 0.874 | 0.094 | Botulinum neurotoxin type A inhibitor | 0.094 0.011 DBMET00638 | DBMET00638 | |
| 0.001 | 0.872 | 0.06 | Ribonucleoside-diphosphate reductase inhibitor | 0.06 0.034 DBMET00638 | DBMET00638 | |
| 0.002 | 0.874 | 0.075 | Squalene epoxidase inhibitor | 0.075 0.012 DBMET00638 | DBMET00638 | |
| 0.003 | 0.876 | 0.089 | Histone deacetylase SIRT3 inhibitor | 0.089 0.013 DBMET00638 | DBMET00638 | |
| 0.004 | 0.878 | 0.208 | Insulin sensitizer | 0.208 0.066 DBMET00638 | DBMET00638 | |
| 0.002 | 0.876 | 0.107 | Histamine H2 receptor agonist | 0.107 0.004 DBMET00638 | DBMET00638 | |
| 0.001 | 0.877 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 DBMET00638 | DBMET00638 | |
| 0 | 0.878 | 0.019 | Adenosine A2a receptor agonist | 0.019 0.008 DBMET00638 | DBMET00638 | |
| 0.001 | 0.882 | 0.064 | Purinergic P2Y15 antagonist | 0.064 0.002 DBMET00638 | DBMET00638 | |
| 0.004 | 0.886 | 0.047 | Heme oxygenase inhibitor | 0.047 0.019 DBMET00638 | DBMET00638 | |
| 0.001 | 0.887 | 0.075 | Carbonic anhydrase IV inhibitor | 0.075 0.012 DBMET00638 | DBMET00638 | |
| 0.004 | 0.891 | 0.143 | Pregnane X receptor agonist | 0.143 0.067 DBMET00638 | DBMET00638 | |
| 0.004 | 0.906 | 0.111 | Proteasome inhibitor | 0.111 0.073 DBMET00638 | DBMET00638 | |
| 0.003 | 0.91 | 0.246 | Calpain 2 inhibitor | 0.246 0.153 DBMET00638 | DBMET00638 | |
| 0.001 | 0.911 | 0.02 | Adenosine A2 receptor agonist | 0.02 0.008 DBMET00638 | DBMET00638 | |
| 0.001 | 0.911 | 0.042 | Delayed rectifier potassium channel blocker | 0.042 0.019 DBMET00638 | DBMET00638 | |
| 0.003 | 0.915 | 0.098 | Histone deacetylase SIRT2 inhibitor | 0.098 0.03 DBMET00638 | DBMET00638 | |
| 0.002 | 0.916 | 0.061 | Histone deacetylase inhibitor | 0.061 0.052 DBMET00638 | DBMET00638 | |
| 0 | 0.931 | 0.01 | Angiotensin AT2 receptor agonist | 0.01 0.008 DBMET00638 | DBMET00638 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |